Table Of Content

index to Volume Thirty Index of Issues: January, 1-98: February, 99-186; March, 187-272; April, 273-368; May, 369-476; June, 477-532 ; July, 533-592; August, 593-670; September, 671-735; October, 737 802; November, 803-870; December, 871-934. . INDEX OF AUTHORS Brown C, 575 Cuesta M, 280 Fortenberry JD, 49 Abel M. 362 Brown DR, 246 Foxman B, 216, 750 Abraham CD, 549 Brown P, 689 D Fox TL, 124 Abrahamowicz M, 581 Brunham RC, 297 Dallabetta G, 664 Franco E, 581 ACSAG Investigators. 6 Buchanan K, 273 Dan M, 794, 835 Fredlund H, 205 Adams AL. 764 Bull SS, 15 Davies SC, 671 French PP, 433 AAAdhdlIaemmr asn B .E JK,8, 7 43 17194 BBBuuurrrkkm haanRr Dd,t W J5,G7, 5 369694 dDDeee em lbasTa S ,C uEe,4 v1a498s 3 C, 395 FFurcihesd maFnD , H,1 663 06, 531 Ahmed HJ, 114 Butler N, 609 De P, 497 Fuchs SC, 166 Funkhouser E, 689 Alarcon J, 273 de Sanjose 3; lary M. 46 Cc Desmond R, 335 Furuya R, 629 Alcald B. 395 acho J, 395 Detels R, 327, 411, 803 G 1l exander L. 193 ‘allahan DB, 340, 645 De Vuyst H, 137 Gala P, 335 Almirall R. 788 aalmvpebt elHl, 4P,9 3 Diamond C, 425 Gallinelli A, 707 Alter MJ, 340 Diao J, 600 Amestoy GM, 5< 93 aimmpp¢o s PE. +e 2 3 Diaz M, 788 Garcia MJ, 280 Amida X, 664 rel D, 174 DiCello AC, 246 Garcia PJ, 379 Anderson JE. 719 arrehoF , 280 Dicker LW, 472 Garin CA, 756 Ande1.r son K, O191 RARRaR rrAiRlRlAoC D. P2D73 Dickson N, 818 Garland S, 362, 886 Anderson LA. 30 ( arvalho SE, 694 DiClemente RJ, 57, 211, 449, 634, Garnett GP, 149, 379 Anoma CK, 284 ( asey_ S, 877A4 909 Gaydos CA, 64, 306, 539, 769 Antolin I, 395 ( asper C, 713 Dilley J, 331, 874, 919 Gaydos JC, 539, 769 Antonio MAD ( astellanos S, 195 Dillon J-AR, 443 Geisler WM, 160 Apter D. 120 ( astle PE, 575 Donegan E, 905 Ghys PD, 284 Aral SO, 39 ( atala I, 788 Dorst D, 75 Gift TL, 502 Armenian HK, I! ( elentano DD. 185 Douglas JM, 562 Gilbert BC, 719 Aronson N, 713 ( hagas C, 694 Douglas JM Jr, 15 Gilbert LK, 193 Arreaza L, 395 ( haowanachan T, 320 Douglas W, 411, 685 Gillespie B, 216 Morrow ( haw JK. 509. 661 Downs J, 71 Gilroy C, 129 ( hemeris G, 680 D’Souza G, 872 Ginocchio RHS, 99 ( hen R, 600 Dutro SM, 756 Girasek DC, 531 ( hen S. 362. 609 Girolomoni G, 157 ( hernesky M, 345, 880, 905 Gisselquist D, 183 Bachmann LH, 20, 3 ( herpes TL, 405 Eckert LO, 357 Gittelsohn J, 149 Biickman A, 205 ( hesson HW, 419 Edmunds WJ, 379 Baker MA, 650 ( hilongozi D, 516 Egger M, 129 Glezerman M, 835 Bala M, 523 ( hiossi G, 707 Ellen JM, 234 Gmach RD, 440 Bandama C, 284 ( hoi K-H, 91 Engelberg R, Golden MR, 490, 742 Barcellos NT. 166 ( hong S, 345 Ennis DM, 512 Goldie SJ, 369 Barivelo I 604 ( hrisnadarmani VAMA, 671 Erokhina O, 680 Gollub EL, 433 Bass DC ( hristensen NO. 262 Escoffery © 315 Gomez CA, 91 Becker 6 ( hu B-C, 614 Espinosa E, 292 Gooding E, 483 Begley E, 211 iaffi L. 671 Esquivel CA, 195 Goossens H, 25 Behets I iesielski CA. 650 Essex M, 187 Goossens W, 25 Beltrami JI intorino M, 680 Essien EJ, 110 Gotuzzo E, 273 n SM laeys P, 137 Esteban JI, 470 Gourley PJ, 399 lark R, 839 Esteban R, 470 Greenland S, 411 -rn) stFeMi,n 7KT5,2 199 ocuroccia B, 15 Ethier K, 809 Gregorich SE, 91 ohen DA, 844 Ettiégne-Traore V, 284 Gregson S, 779 R. 866 ohen MS, 516 Ezcarzaga MLB, 195 Grenfell BT, 388 lford JM, 502 ohn DL, 399 F Grewal N III, 530 BBBlolaeezhjenase nr ¢ D I ooynnenn edlelR- GAl,e zF A1,0 C79J 9, 266, 549 -‘aaiirrlcehyo k CKM,P , 88690 1 GGrriicnes teAa,d 3O6,2 91 Boe onnolly C, 1, 241 ‘alk L, 205 Grosshans JF, 193 ‘arley TA, 75, 654, 839, 844 Grujnberg A, 680 Boerma JT yplan PM, 246 Grujnberga V, 680 Bolan G , Corey | 174, 425, 713 “awzi WW, 187 Guan J, 803 Borrell N osgrove Sweeney YT, 568 Feij6 G, 694 Bosch FX osta MC, 581 Feldblum PJ, 440 Guardia J, 470 Boselli F, 707 osta PL, 694 Fenton J, 33 Gubinelli E, 157 Boskey ER, 107 ourtoisB , 273 Fernandez-Esquer MI Guerino C, 114 Bowen AM, 57 raig T, 83 Fernandez I, 809 Gunnarsson E, 114 Branovskaja M. 680 ranston B, 5 5 Fichtenberg CM, 825 Gunn RA, 340, 645 Brennan CH, 34( Crosby RA, 57 . 211, 634, 909 Fife KH, 246 Gutierrez AA, 195 Brewer T. 914 CruNF,m 7 13 Flaks RC, 399 Gutierrez L, 273 Brodine S, 545. 7 Cruz-Valdez A, 549 Font R, 788 Guzman D, 10 926 INDEX OF * AUTHORS Sexually Transmitted Diseases ¢ December 2003 H Juschenko A, 680 Lind I, 178 Miller JM Jr, 728 Haikala O, 737 Lipova E, 680 Miller WC, 516 Hale S, 901 K Lister NA, 886 Mills J, 232 Hammer GP, 919 Kahn RH, 654, 700, 844 Liu H, 327 HHaanndcshfairedl d B,H H5 75 49. 490. 742 KKKaaalprdiiogmra SJSS,HA ,,3 621 18479 LLil anXe,s 32R7, 10, 443 MMiinnndiesl AAM , 5: HHaartdzieclkl TJ,, 6444 0 Karwalajtys T, 880 LLlloovpe raAs, 1B0,, 748483 MMiknaoyr a-PM, wa72m3b uri D, 149 HHaayweess PS, E,8 863 5 KKaauutna inKe, n 36H2, 737 LLooebbo LT,T ,8 7649 4 MMoodeenscihtt TSRK,, 170674 Kaydos-Daniels SC, 516 Hebb JK. 756 Lolis S, 844 Moncada J, 575, 905 HHHHHeeeeeerrrcsnnnk aaamnnnaPddSdne,ee z zz- (-1T M0GM7,aT a,r sqt1ue36le46lz a nlo sC, 5A 49 2~ 66 KKKKKeeeeaenlnzltlne oymg CKbgKB eG,, E ,T AP45,97N ,1, 7] 536335 131,1 6, 913968 . 813 LLLLLoooooruvnwiiednaelnd eeesrDssB ,, M5MC3S9O3M3,1,, , 19744 1639 MMMMMooooorronriadresnlono eeony J SJK,L, ,P W ,,55 942 3188, 38 52041 Herrera L, 593 Kerani RP, 742 Lumpkins J, 335 HHHHHiieoolrrbfloribfseesmrer a on SM 1L,RM ,,I 6F, 2 57919,3 5 5,11 662 5778 Pal KKKKKiiiiilsplmps m iiaknEra,gAx reA ir5, 1P6RH 8P,,,1 3 14293,02 0 75, 214, 731, 839 LLMuyarocinaesl uMsENoE ,, M,13 04 9M2 0 MMMMMMuoousscssugoheuyawilrabroee ioyy aS DELPJ,K,,, E E ,,651 408375978621 5 64 HHHooolgmmbaeensn RKMKK,, , 4492047,03 74+4432 / 9 190) KKliawueslnu6e 6r1 ,I E,J D8.1 138,7 3 318.7 4, 3698.1 9 509. 609. MMaafcac KKeEi,l nlna3or2 7n D,S , 482850 MMuulndoezr NP,G H5,9 3,6 3798 8 Hook 8E50W Il, 20 335 369 Sl KKllejtuekri naB , | 137O SU MMaaggindu s DJ,M , 3705 , 731, 839 MMuurrirlalyo PPJ,, 437400 Hoover DR, 433 Kobayashi I, 629 Maher JE, 75, 83 Myers L, 75, 839 Horner P, 129 Koenig L, 809 Mahony J, 345 N Hotta H, 629 Kohl K, 650 Majkowski JM, 854 National Gonococcal Surveil- Howard M SRO Koroku M 629 Manongi R, 187 lance Program Members, Howell MR, 539, 769 Koumans EH 700 Margolis HS, 340 896 Howe SR 4 Kozachenko V, 680 Marina RB, 226 National Institute of Mental Hoxworth T, 83 Krantz E, 174, 310 Markowitz LE, 49, 320, 650, 700 Health Collaborative HIV HHusgiheehs J,Y- H, 2736,4, 77566‘ ) KKrriasuttj-aBnescshoenr M,J R, 24292 1 MMaarrtrealzl zoM , JM4,7 0 99, 890 P80r3e vention Trial Group, Hu L, 803 Krohn MA, 405 Martin DH, 49, 844 Neilsen GA, 671 Hultunen-Back | 3 Krunfly C, 593 Martinez I, 10 Nelson MB, 306 Humblet O, 818 Kruse N, 664 Martin I, 896 Nerovjna R, 680 Hussain A, 588 Kumamoto Y 629 Martinko T, 901 Ness RB, 71 Hutapea N, 178 Kumari S, 523 Martinson F, 516 Newman SB, 306, 531 Hutchinson ML, 57 Kumwenda N, 185 Masenga EJ, 187 Ng L-K, 896 Kunishima Y, 629 Mastro TD, 320 Niccolai LM, 75 I Kus J, 64 Matos E, 593 leven M, 25 Maupin RT, 728 Niesters HGM, 639 Nikitina M, 680 Irwin K, 30, 866 Maurice CE, 284 Ivanchenko O, 680 ackey PC, 512 Mayaud P, 483 Nishimura M, 629 Iwasawa A, 629 aga M, 284 Mayberry R, 723 Nsuami M, 367, 728 agergard T, 114 Mbizvo E, 588 Nyamukapa C, 779 J Lammens C, 25 Mbwana J, 114 Oo Jacobson LP, 199 and DJ, 348 McClure M, 129 O’Brien ME, 731 JJJaaancmgoi bssoD n, RJ3D.4 .5 ,8 532987 8 0 aanintpgie druoDs , MJ5IA7,, 71604 MMccFFaarrllaanned MW,, 3153 1, 609, 919 OOhk saMnKe,n 4H9,, 162809 Jansen KU, 246 atka M, 433 MMccGKeeee ZKAT, Jr5,3 05 39, 769 Olafsson JH, 249 Jayaraman GC, 315 au A, 896 McLean CA, 650 OOl'cLéena ryP , M2,0 5 362 Jeansson S, 588 au JTF, 600, 620, 827 Medland NA, 886 Olmsted SS, 257 Jeeyapant S, 320 azcano-Ponce E, 549 Medrano JC, 195 Osterhaus ADME, 639 JJJJJeeooonnhhhknanniinssnnsoosgsnn so nF GJSJ,,, M B,8,61 3 59 4962, 83 04 844 LLLLLaeeeezeeehz maJJaMrHKo,n,,t t8o82J0 73S3,24 T,7 6145 7 MMMMMeeeeeirhrhjttceezahur as n GStCJD ,JA, ,L JM8, 20,16154 839 5 93, 788 OOOOttvwteaeorsn oks aB ,iL ,nM 6eL7n2,18 0,O 1T2,249 2,3 883 95 Johnson SM, 533 Le Pont F, 6 Mestad RE, 728 P Jolley L, 193 Leutscher PDC, 262 Mettey A, 909 Paavonen J, 120, 737 Jones M, 335, 850 Levine D, 634 Meyerhoff AS, 859 Padian NS, 556 Jénsdoéttir K, 249 Levine WC, 472 Meyers M, 134 Paffel JM, 872 Jordan N, 723 Liang G, 803 Meyerson BE, 614 Page-Shafer K, 331, 919 Judrez-Figueroa L, 266 Li H, 443 Meyn LA, 257, 405 Pajanidi J, 680 Judson FN, 562 Li L, 803 Mhalu F, 114 Palacio V, 280 Junquera ML, 292 Limones DEC, 195 Michaud JM, 533 Palefsky JM, 575 Jurstrand M, 205 Lindberg M, 205 Migliani R, 262 Palma S, 10 INDEX OF * AUTHORS 927 Parker KA, 39 Rosana Y, 25 Stamm WE, 160, 357 van der Snoek EM, 639 Partohudoyo S, 671 Rose E, 57, 211, 634 Stanberry LR, 752, 801, 854 van Doornum GJJ, 639 Patel D, 216 Rosenthal SL, 752, 774, 801, 854 Steingrimsson O, 249 Van Dyck E, 284 Patnaik JL, 15, 562 Ross MW, 110 Stein ZA, 433 Van Griensven F, 320 Patten J, 671 Rothenberg R, 478 Stephan K, 713 Van Looveren M, 25 Patton DL, 568 Rotheram MJ, 803 Sternberg M, 49, 320 Vanmali T, 241 Paukku M, 120 Rothman RE, 143 Steyaert S, 137 Van Marck E, 137 Paul C, 818 Rousseau M-C, 581 Stiffman M, 30 Van Renterghem L, 137 Paz-Bailey G, 320 Rousset D, 262 Stine K, 890 Vansteelandt S, 137 Pech N, 6 Ruben M, 443 Stray-Pedersen B, 588 Perdue T, 425 Rudy E, 411, 685 Strickler HD, 575 Vaovola G, 664 PPeettreorvmiacnh ev TA,N , 756,8 0 83, 73 RRuusutt u G,P , 72733 7 SSttruirnme TA,W ,6 85 1, 149, 24] VVaarzeqluae z JAF,, 228800,, 229922 , 395 Pettifor A, 455 Ryan CA, 39 Sturm PDJ, 241 Vazquez JA, 395 Pfister JR, 797 Succop PA, 752 Veenstra DL, 99 Pigott D, 335 S Suchland RJ, 160, 357 Villa LL, 581 Platt L, 46 Sadan O, 835 Sudigdoadi S, 25 Villar H, 395 Platt R, 866 Safarova E, 39 Sugai K, 575 Vlahov D, 199 Podistov J, 680 Sahin-Hodoglugil NN, 455 Su L, 246 Vuylsteke BL, 284 PPootutmerearto l JJ,G ,8 9,3 624 90 SSaalkaas TE,V ,6 291 95 SSuulplaiwviatnk ulE A, S, 36322 0 W Pourbohloul B, 297 Salcedo C, 395 Sutama IN, 671 Wald A, 174, 310, 713, 890 Preiksaitis J, 33 Sam NE, 187, 588 Sutton TL, 901 Wallace MR, 713 Price MA, 516 Samra Z, 794, 835 Su X, 178 Walsh J, 455 Primary Care STI Study Group Samson ET, 671 Svensson LA, 114 Walter E, 809 (GITSAP), 876 Sanchez C, 280, 292 Sweat MD, 149 Waltje A, 134 Prince MA, 593 Sanchez J, 273 Wang Q, 600 Proyecto Concordia Collaborative Sanchez-Zamorano L, 549 SSywrejeati neRn L, K, 716 80 Wang SA, 528 Group, 593 Sanders WM, 512 Syrjiinen S, 680 Ward K, 609 Pshepurko A, 680 Sansom S, 685 T Watts D, 273 Puolakkainen M, 120 Santelli J, 719 Wegner S, 713 Santopietro R, 680 Tabrizi S, 362, 886 Weinberg M, 645 Q Satcher D, 723 Taha TE, 185 Weisbord JS, 914 QQQuuuieinrnt n J,WT ,C4 ,7 01 3573 9, 769 SSaauucdae r G,D N,3 95 124 Tlaakkaehyaasmhia SK,, 662299 WWeeissts B,H L,4 838 50 Schachter J, 575, 905 Taleo H, 362 Whelan M, 866 R Schaffzin JK, 700 Tambis JA, 661 Whitten KL, 348 Rabe LK, 568 Scherf E, 794 Tanda H, 629 Whittington WLH, 49, 160, 742 Ramarokoto C-E, 2 Schiffman M, 575 Tang Y, 866 Wiktor SZ, 284 Ramirez-Arcos S, Schillinger JA, 49 Tao G, 866 Wilkinson D, |, 241 Ramos BPL, 195 Schim van der Loeff M, 483 Tapsall JW, 178 Williams BG, 149 Ransom RL, 49 Schwarcz S, 609 Tasker SA, 713 Williams I, 919 Raphael TL, 614 Seattle Young Men’s Survey Team, Tawes J, 64 Williams ML, 110, 571 Ratelle S, 866 425 Taylor-Robinson D, 129 Wilson TE, 809 Rattray C, 575 Secura GM, 425 Temmerman M, 137 Wingood GM, 57, 211, 634 Ravaoalimalala EV. 262 Sellors J, 345, 880 Terndrup T, 335 Wong E, 331, 919 Raveh D, 835 Shabalova I, 680 Thiede H, 425 Wong T, 497 Ray K, 523 Shafer M-A, 545 Thomas AG, 713 RReegaido naRlR , In3f1e5r tility Prevention Pro SShhaakoa riJsF,h vi1l8i7 A, 39 TThiokmhaonso vaB , L1,2 9 39 WWooondgc oWx, V6,6 1 880 gram, 472 Shiboski SC, 556 Timpson S, 571 Woods R, 455 Workowski KA, 528 Rein MF, 348 Shimizu T, 629 Tosi P. 680 Rekart ML, 297 Short MB, 752, 854 Totten PA, 756 Wu Z, 803 Renjifo B, 187 Siddiqi O, 262 Irepka MJ, 914 xX Reppucci ND, 348 Silverthorn M, 134 Tsidaeva I, 680 Xavier J, 694 Reunala T, 737 Sim6es-Barbosa A, 694 Tsui H, 600, 620 Rhodes SD, 449 Simpson T, 689 Tsukamoto T, 629 Y Rice P, 71 Sinclair MF, 650 Tulloch S, 64 Yacoub W, 497 Richardson-Alston G, 75, 731 Singh A, 315, 497 Turkheimer E, 348 Yarber W, 134 Richardson E, 880 Sitati S, 137 Turner KR, 331 Yeh JM, 369 Richter HE, 71 Sizemore JM, 512 U Yin Y, 327, 803 Rietmeijer CA, 15, 399, 562, 659 Skinner RB, 124 Urassa M, 779 Yokoe D, 866 Rinaldi J, 874 Smith A, 886 Uribe-Salas F, 266 Yuan W, 600 Roberts CM, 797 Snijders PJF, 788 Roberts JN, 226 Soper DE, 71 \ Z Rogers C, 433 Sosa J, 10, 443 Valdés EA, 10 Zakharenko S, 680 Rohan LC, 257 Sozaeva L, 680 Valleroy L, 425 Zakharova T, 680 Rohan TE, 581 Spear SJ, 797 Valtrex HS230017 Study Group, Zenilman JM, 143 Rojas C, 246 Spencer NE, 83 226 Zhang G, 914 Romanowski B, 33, St. Lawrence JS, 39, 490 van den Brule AJC, 593 Zimba D, 516 Stamm C, 71 van der Meijden WI, 639 Zuma K, 149 Sexually Transmitted Diseases ¢ December 2003 INDEX OF SUBJECTS A Army recruits Acquired immunodeficiency syndrome. See Human immunodeficiency vi- female, chlamydia prevalence in, 539, 545 (editorial) rus infection male, HIV-infected, human herpesvirus-8 infection in, 713 Adjudicated African American adolescents, risk behavior of, 634 ASTDA awards, 477, 478 Adolescents Australia, gonorrhea and chlamydia screening in, at male-only saunas, 886 acceptability of urine screening for gonorrhea and chlamydia in, 850 Azithromycin adjudicated African American, risk behavior of, 634 for chlamydial infection, partner-delivered partner treatment with, 49 dual use of condoms and hormonal contraceptives by, 719 for incubating syphilis, cost-effectiveness of, 502 female N. gonorrhoeae resistance to, in Cuba, 443 nonexclusivity in romantic relationships of, 752 B topical microbicide use by, 854 Bacterial vaginosis genital herpes in, HSV type | as predominant cause of, 797 glycosidase and proteinase activity in, 257 high-risk, discordant sexual partnerships of, 234 HSV-2 infection and, 405 HSV-2 infection in, sexual and demographic risk factors for, in Mexico, in pregnancy, management of, 645 549 rapid diagnostic kit for, in Gambia, 483 pregnant African American syndromic management of, with/without HIV-1 coinfection, | continued risky sex among, 57, 211, 214 (editorial) treatment algorithms for, for sex workers, in Céte d’Ivoire, 284 with older partners, STD prevalence among, 211, 214 (editorial) Barrier contraceptives. See also Condom use risk behaviors of, in Thailand, 320 acceptability and product choice as indicators of use of, 556 screening recommendations for, 367 (letter) Bathhouses, male-only, gonorrhea and chlamydia screening in, 886 Africa. See also specific countries Belarus, sexual habits and HPV infection in females in, 680 bacterial vaginosis in Birth control pills, condom use with rapid diagnostic kit for, 483 by adolescents, 719 treatment algorithms for sex workers in, 284 by HIV-infected vs. non—HIV-infected women, 809 cost-effectiveness of diagnosis and treatment protocols for chlamydia Brazil, HIV risk factors and prevalence in, 166 and gonorrhea in, 455 Bridge members, of adolescent sexual networks, 234 genital ulcer disease in, etiology and HIV co-infection in, 114 HIV-1 transmission in, migration and, 149 Cc HIV prevalence in, 183, 185 (letters) Canada HIV risk factors in, 183, 185 (letters), 262 gonorrhea outbreak in, 497 HPV distribution in family planning clinic attendees in, 137 N. gonorrhoeae drug resistance in, 896 HSV type 2 infection in syphilis outbreak in, patient characteristics with male-to-male vs. het- prevalence of, 187, 588 erosexual acquisition in, 310 risk factors for, 187, 262 Candidal vaginitis, treatment algorithms for, for sex workers, in Cote participatory mapping of sex trade in, 664 d'Ivoire, 284 sex workers in, STD treatment algorithms for, 284 Capture-recapture methodology, in sex trade mapping and sex worker syndromic management in, role of community pharmacists in, 609 enumeration, in Madagascar, 664 uneven HIV prevalence in, 779 Caribbean, drug-resistant N. gonorrhoeae in, 10, 443 African Americans. See also Race/ethnicity CDC case definition, of pelvic inflammatory disease, predictive value of adjudicated adolescent, risk behavior of, 634 clinical diagnostic codes for, 866 gay, hepatitis B vaccination in, 449, 685 Centers for Disease Control and Prevention (CDC), treatment guidelines of pregnant adolescent for chlamydia, adherence to in managed care organizations, 30 continued risky sex among, 57 need for revision of, 528 (letter) with older partners, STD prevalence among, 211, 214 (editorial) Cervical gonococcal infections, in Indonesian sex workers, 671 Age Cervical neoplasia grade, STD coinfections and, in Jamaica, 575 cervical infection with multiple HPV types and, 581 Cervicovaginal secretion collection, self-sampling methods for, 107, 306, female, condom use and, 216 769, 880 partner China. See also Hong Kong in discordant adolescent sex partnerships, 234 market vendors in, STD prevalence and characteristics in, 803 STD prevalence in adolescent girls and, 211, 214 (editorial), 234 STD/HIV prevention in, needs assessment for, 600 AIDS. See Human immunodeficiency virus infection syndromic management of male STDs in, 327 Anal nodular herpes simplex virus infection, in AIDS, 157 Chlamydial heat-shock protein 60 KDA antibodies, 157 Anal warts, imiquimod 5% cream for, 124 in chronic nongonococcal urethritis, 129 Anogenital warts Chlamydial infection 5% imiquimod cream for, 124 adolescent risk behaviors and, in Thailand, 320 frequently asked questions about, 193 CDC guidelines for, adherence to in managed care organizations, 30 Antibiotics cervical neoplasia grade and, in Jamaica, 575 prophylactic, for syphilis, 844 cervicovaginal specimen collection for, self-sampling methods for, 107 topical, acceptability of to adolescent girls, 854 306, 769, 880 Antimicrobial resistance, of N. gonorrhoeae contact tracing for, genotyping and, 205 in Canada, 896 cost-effectiveness of diagnosis and treatment protocols for, in Africa, in Cuba, 11, 443 455 in India, 523 gonococcal coinfection and, in young women, 472 in Indonesia, 25, 178 HPV infection and, in men who have sex with men, 639 in Spain, 395 importation of, spatial bridging in, 742, 750 (editorial) Antiretroviral therapy in incarcerated women adherence to, transmission risk behaviors and, 399 preferred sampling methods of, 306 availability of, impact of on risk behaviors, 562, 765 surveillance for, 64 Argentina, HPV infection in, prevalence of in females, 593 increased incidence of, in Finland, 737 INDEX OF SUBJECTS 929 male, epidemiologic trends in, in Spain, 280 acceptability and product choice as indicators of use of, 556 molecular epidemiology of, in Iceland, 249 oral, condom use with partner notification for, low coverage of, 490 by adolescents, 719 patient-delivered partner therapy with azithromycin for, 49 by HIV-infected vs. non—-HIV-infected women, 809 patient-delivered therapy for, 509 Core groups in pregnant African American teens with older partners, 211, 214 (edi- geographic stability of, 825 (editorial) torial) stability of sexual behavior in, 818 prevalence of Correspondence, 183, 185, 367, 368, 526, 528, 531 n female Army recruits, 539, 545 (editorial) Cost, average lifetime, of pelvic inflammatory disease, 369 n female emergency department patients, 335 Cost effectiveness in Finland, 737 of azithromycin, for incubating syphilis, 502 in Indonesian sex workers, 671 of diagnosis and treatment protocols for chlamydia and gonorrhea, in in Mexican sex workers, 195 Africa, 455 in pregnant women, in Vauatu, 362 of syndromic management in pharmacies in ROTC cadets, 901 in Peru, 379 eening for. See also Screening in South Africa, 609 in adolescents, 367 (letter) age range for, 120 Cote dIvoire, treatment algorithms for bacterial vaginosis in sex workers in asymptomatic men, ligase chain reaction with/without leukocyte in, 284 Counseling, telephone, in Italy, 707 esterase test for, 99 in community based mobile clinic, 654 Cross-border sexual networks, in Hong Kong, 827 in Indonesian sex workers, 671 Cuba, drug-resistant N. gonorrhoeae in, 10, 443 at male-only saunas, 320 D risk factor vs. clinically based. 901 Day laborers, urban immigrant, STD prevalence among, 661 sentinel site surveillance for, 20 Detained African American adolescents, risk behavior of, 634 serovar-clinical manifestations correlation in, 160 Developing countries. See also specific countries syndromic management of, in China, 327 adolescent risk behaviors in, 320 urine testing for in males, 345 bacterial vaginosis in self-sampling methods for, 306, 769 rapid diagnostic kit for, 483 treatment algorithms for sex workers in, 284 hlamydia trachomatis genotyping of, contact tracing and, 205 cost-effectiveness of diagnosis and treatment protocols for chlamydia serovars of, longitudinal assessment of, 357 and gonorrhea in, 455 Cigarette smoking, HSV 2 infection and, 405 drug-resistant N. gonorrhoeae in, 10, 178, 443 Ciprofloxacin, gonococcal resistance to. See also Antimicrobial resistance genital ulcer disease in, etiology and HIV co-infection in, 114 in India, 523 HIV-1 transmission in, migration and, 149 in Spain, 395 HIV prevalence in, 183, 185 (letters) Circumcision, HSV-2 infection in females and, 405 HIV risk factors in, 187, 262 Clinic attendees. See Family planning clinic attendees; Sexually transmit HPV distribution in family planning clinic attendees in, 137 ted disease clinic attendees HSV type 2 infection in College students. See also Adolescents prevalence of, 187, 588 acceptability of STD vaccination in, 774 risk factors for, 187, 262 genital herpes in, HSV type | as predominant cause of, 79 laboratory testing for STDs and HIV infection in, 905 Commercial sex workers. See Sex workers N. gonorrhoeae antimicrobial susceptibility in, 25, 178 Community-based screening, effectiveness of, 654. 659 (editorial) participatory mapping of sex trade in, 664 Community pharmacists, as treatment providers rapid diagnostic kit for bacterial vaginosis in, 483 in Peru, 379 sexual partnership and concurrency in, quantitative assessment of, 6 in South Africa, 609 sex workers in Compliance, with antiretroviral therapy, transmission risk behaviors and, sociodemographic dynamics and STDs in, 266 399 STD treatment algorithms for, 284 Concurrency, quantitative assessment of, 6 STD prevalence in pregnancy in, 362 Condom use. See also Risk behavior/factors STD prevention in, for sex workers, 273 acceptability and product choice as indicators of, 556 syndromic management in, role of community pharmacists in, 609 by adjudicated African American adolescents, 634 syndromic management in pharmacies in, 379, 609 female condoms syndromic management of male STDs in, 327 icceptability and product choice as indicators of, 556 uneven HIV prevalence in, 779 patterns and predictors of, 91, 556 Diagnostic testing, in developing countries, 905 use-effectiveness of, 433, 440 (editorial) by HIV-infected persons, in rural areas, 134 Discordant sexual partners with hormonal contraceptives of high-risk adolescents, 234 by adolescents, 719 of pregnant African American teens, 211, 214 (editorial) by HIV-infected vs. non—HIV-infected women, 809 Douching by older women, 216 early-onset, health beliefs and high-risk behavior and, 689 promotion of, in China, 600 HSV-2 infection and, 405 by sex workers, in Peru, 273 reasons for continuing or stopping, 71 Condylomata acuminata Drug resistance. See Antimicrobial resistance frequently asked questions about, 193 Drug use. See Substance use/abuse imiquimod 5% cream for, 124 Dry swab sampling Contact tracing. See Partner notification for HPV polymerase chain reaction assay, in males, 246 Contraceptives self-performed, for cervicovaginal specimen collection, 107, 306, 769, barrier. See also Condom use 880 930 INDEX OF SUBJECTS Sexually Transmitted Diseases ¢ December 2003 E trichomoniasis treatment in, in Malawi, 516 Economic factors. See under Cost treatment algorithms for, for sex workers, in Céte d'Ivoire, 284 Editorials, 10, 46, 90, 214, 232, 440, 659, 750, 801, 825 urine testing for, acceptability of to adolescents, 850 Education, patient, for HPV infection, 193 Guatemala, sex workers in, sociodemographic dynamics and STDs in, 266 ELISA, time course to seroconversion by, in HSV-1 infection, 310 Emergency department patients, female, gonorrhea and chlamydia preva- H lence in, 335 Health-seeking behavior, of male STD clinic attendees with/without reg- Emergency-department screening, in inner city vs. urban sites, 143 ular doctors, 512 Ethnicity. See Race/ethnicity Hepatitis, vaccination for, hepatitis A/B vs. hepatitis B vaccine for, 859 Hepatitis A, in men who have sex with men prevalence of, 425 Family planning clinic attendees risk factors for, 425 female condom use among, 91 vaccination for, 411, 425, 685, 859 HPV distribution in, 137 Hepatitis B Female condoms. See also Condom use in men who have sex with men acceptability and product choice as indicators of use of, 556 prevalence of, 425 patterns and predictors of use of, 91, 556 risk factors for, 425 use-effectiveness of, 433, 440 (editorial) vaccination in, 411, 425, 449, 685, 859 FemExam, for bacterial vaginosis, 483 risk factors and immunity for, in STD clinic attendees, 914 Financial factors. See under Cost Hepatitis C Finland, chlamydial infection in in men who have sex with men, 425 increased incidence of, 737 screening for, in STD clinic attendees, 340 screening for, 120 seroprevalence of and risk behaviors for, in STD clinic attendees, Fluoroquinolones, resistance to. See also Antimicrobial resistance sexual transmission of CDC treatment guidelines and, 528 (letter) after IUD removal, 470 rates of, 919 G HerpeSelect ELISA, time course to seroconversion by, in HSV-1 infection, Gambia, rapid diagnostic kit for bacterial vaginosis in, 483 310 Gap length, STD transmission and, 221 Herpes simplex virus infection Gays. See Men who have sex with men genital ulcer disease as, in Tanzania, 114 Genital herpes. See Herpes simplex virus infection HPV infection and, in men who have sex with men, 639 Genital ulcer disease, 124 nodular perianal, in AIDS, 157 HIV coinfection and prevalence of and risk factors for, in lesbians, 890 in Tanzania, 114 suppressive vs. episodic treatment for, patients’ preference for, 226, 232 treatment response and, 241 (editorial) HSV-2 as etiologic agent of, in Tanzania, 114 type | syndromic management of, in China, 327 in college students, 797 Genital warts in first episode, 801 (editorial) frequently asked questions about, 193 in Israel, 794 imiquimod 5% cream for, 124 natural history of, 174 Geographic stability, of core groups, 825 (editorial) time course of seroconversion by ELISA in, 311 Glycosidase activity, in bacterial vaginosis, 257 type 2 Gonorrhea/gonococcal infection cervical neoplasia grade and, in Jamaica, 575 adolescent risk behaviors and, in Thailand, 320 in persons seeking repeat HIV testing, 33 chlamydia coinfection in, in young women, 472 in pregnant Israeli women, 835 detection of HPV on external genitalia of males with, 629 prevalence of, in Tanzania, 187 drug-resistant risk factors for in Canada, 896 in females, 405 in Cuba, 11, 443 in Mexican adolescents and young adults, 549 in India, 523 in Tanzania, 187 n Indonesia, 25, 178“a Highly active antiretroviral therapy in Java, Indonesia, adherence to, transmission risk behaviors and, 399 in Spain, 395 impact of on risk behaviors, 399, 562, 764 etiologic and epidemiologic trends in, in Spain, 280 Hispanic day laborers, urban, STD prevalence among, 661 HPV infection and, in men who have sex with men, 639 HIV infection. See Human immunodeficiency virus infection importation of, spatial bridging in, 742, 750 (editorial) Homosexuals. See Lesbians; Men who have sex with men in incarcerated women, surveillance for, 64 Hong Kong. See also China outbreak of, in northern Alberta, Canada, 497 behavioral surveillance surveys of male clients of female sex workers in, partner notification for, low coverage of, 490 620 prevalence of cross-border sexual networks in, 827 in female emergency department patients, 335 Hormonal contraceptives, condom use with in Indonesian sex workers, 671 by adolescents, 719 in pregnant women, in Vauatu, 362 by HIV-infected vs. non—-HIV-infected women, 809 in women 15 to 24, 472 Human herpesvirus-8 infection rectal, risk factors for, HIV status and, 813 in HIV-infected soldiers, 700 screening for. See also Screening in injection drug users, 199 in adolescents, 367 (letter) Human immunodeficiency virus infection in Indonesian sex workers, 671 adolescent risk behaviors and, in Thailand, 320 at male-only saunas, 320 anonymous counseling and testing sites for, treatment of asymptomatic in pregnancy, 728 STDs at, 874 syndromic management of counseling and testing sites for, treatment of asymptomatic STDs at, 874 in China, 327 dual contraceptive use and, 809 INDEX OF SUBJECTS 93] HAART for, impact of on risk behaviors, 399, 562, 765 Intrauterine device, hepatitis C transmission after removal of, 470 human herpes type 8 infection and, in soldiers, 700 Intravenous drug use. See Injection drug use mortality in, as cause of declining syphilis rates, 419 Israel nodular perianal HSV infection in, 157 genital herpes in, HSV type | as predominant cause of, 794 partner notification for HSV type 2 in pregnant women in, 835 effects of on sexual behaviors and relationship stability, 75 Italy, telephone hotline in, 707 low coverage of, 490 prevalence of, in Malawi, 183, 185 (letters) J risk behaviors/factors fot Jamaica, cervical neoplasia grade in, STD coinfections and, 575 in Brazil, 166 Java, N. gonorrhoeae antimicrobial susceptibility in, 25 changing perspectives on, 764 K impact of HAART on, 562, 764 Kenya, HPV distribution in family planning clinic attendees in, 137 in Madagascar, 262 Klausner, Jeffrey, ASTDA Young Investigator Award recipient, 477 in Malawi, 183, 185 (letters) in rural areas, 134 L screening for. See Screening Laboratory testing, in developing countries, 905 seropositivity for Lactobacillus crispatus capsules, single-use safety study of, 568 disclosure of by patient 731 atino immigrant day laborers, urban, STD prevalence among, 661 dual condom use by women and, 809 “atvia, sexual habits and HPV infection in females in, 680 risk behaviors for rectal gonorrhea and, 813 esbians, HSV infection in, prevalence of and risk factors for, 890 among STD clinic attendees, in Spain, 876 etters to editor, 183, 185, 367, 368, 526, 528, 531, 531531 symptomatic management of bacterial vaginosis in, | eukocyte esterase test, for chlamydial infection, in asymptomatic males, testing for, perceptions of risk and, 764 99 transmission of, effect of migration on, in South Africa, 149 Lice, pubic, epidemiology of, 292 reatment response in genital ulcer disease and, 241 Ligase chain reaction, with/without leukocyte esterase test, for chlamydial trichomoniasis in, associated factors in, 839 infection, in asymptomatic males, 99 uneven prevalence of, in Africa, 779 iman papillomavirus DNA, detection of on external genitalia of males M with urethritis, 629 Madagascar iman papillomavirus infection HIV risk factors in, 262 participatory mapping of sex trade in, 664 asymptomatic, in males with urethritis, 629 cervical, in Spain, 788 Malawi cervical neoplasia grade in, STD coinfections and, in Jamaica, 575 HIV prevalence and risk factors in, 183, 185 (letters) in family planning clinic attendees, in Kenya, 137 syndromic treatment of urethritis in, trichomoniasis treatment in, 516 frequently asked questions about, 193 Male-to-male sexual activity. See Men who have sex with men with multiple HPV types, age and cytologic abnormalities and, 581 Managed care organizations, adherence to CDC guidelines for chlamydial PCR assay for, sampling methods for, 246 infections in, 30 prevalence of, in Argentine women, 593 Mapping, of sex trade, in Madagascar, 664 Human T-cell lymphotropic virus type |, cervical neoplasia grade and, in Mathematical tocls, for assessing effectiveness of intervention scenarios, 388 Jamaica, 575 Men who have sex with men I gonorrhea and chlamydia screening in, 886 Iceland, chlamydial infection in, molecular epidemiology of, 249 at male-only saunas, 886 Imiquimod 5% cream, for exterrial genital and perianal warts, 124 hepatitis vaccination for, 411, 425, 449, 685, Immigrant day laborers, urban, STD prevalence among, 661 HPV infection in, STD coinfection and, 639 Immunization pubic lice in, 292 for hepatitis risk behaviors of hepatitis A/B vs. hepatitis B vaccine for, 859 availability ofH AART and, 562 for men who have sex with men, 411, 425, 449, 685 in Canadian syphilis outbreak, 315 among STD clinic attendees, 914 at sex resorts, 909 for STDs, acceptability of among college students, 774 self-reported sexual activity of, 526 (letter) Incarcerated persons syphilis outbreak among, 872 \frican American adolescent, risk behavior of, 634 young African American, hepatitis B vaccination in, 449 female Metronidazole, for trichomoniasis, in syndromic treatment of urethritis, in chlamydia in Malawi, 516 preferred sampling methods for, 306 Mexico surveillance for, 64 chlamydia prevalence in, 195 epidemiologic study on STDs in, 531 (letter) HSV-2 infection in, sexual and demographic risk factors for, in adoles- gonorrhea in, surveillance for, 64 cents and young adults, 549 India, ciprofloxacin- and penicillin-resistant N. gonorrhoeae in, 523 sex workers in, sociodemographic dynamics and STDs in, 266 Indonesia urban day laborers from, STD prevalence among, 661 laboratory testing for STDs and HIV infection in, 905 Microbicides N. gonorrhoeae antimicrobial susceptibility im, 25, 178 N. gonorrhoeae resistance to sex workers in in Canada, 896 gonorrhea/chlamydia screening in, 671 in Cuba, 11, 443 STD prevalence in, 671 in India, 52 3~S Injection drug use in Indonesia, 25, 178 HIV prevalence and, in Brazil, 166 in Spain, 395 human herpesvirus type 8 infection and, 199 prophylactic, for syphilis, 844 by sex workers, in Russia, 46 (editorial) topical, acceptability of to adolescent girls, 854 Internet, as information resource, for at-risk populations, 15 Microwell-plate—based PCR assay, for Vycoplasma genitalium, 756 Intervention scenarios, mathematical tools for, 388 Migrant laborers, urban Latino, STD prevalence among, 661 932 INDEX OF SUBJECTS Sexually Transmitted Diseases ¢ December 2003 Military recruits preterm labor and, 645 female, chlamydia prevalence in, 539, 54: (editorial) continued risky sex during, among African American adolescents, $ male, HIV-infected, human herpesvirus-8 in fection in, 713 gonorrhea screening in, 728 Mobile community-based screening, effectiveness of, 654, 659 (editorial) HSV-2 infection in, in Israel, 835 Mycoplasma genitalium, microwell-plate—based PCR assay for, 756 STD prevalence in, in Vanuatu, 362 Preterm labor, bacterial vaginosis and, 645 N Prevention Neisseria gonorrhoeae, antimicrobial susceptibility of Internet information sources for, 15 in Canada, 896 needs assessment for, in China, 600 in Cuba 1] , 443 in sex workers, in Peru, 273 in India 9° 3 State policy support for, 614 in Indonesia, 25, 178 Prisoners in Spain, 395 African American adolescent, risk behavior of, 634 Netherlands, HPV infection in gay men in, STD coinfection and, 639 female New Independent States of Soviet Union, sexual habits and HPV infection chlamydial infection in in females in, 680 preferred sampling methods for, 306 Nodular perianal herpes simplex virus infection, in AIDS, 157 surveillance for, 64 Nongonococcal urethritis epidemiologic study on STDs in, 531 (letter) chronic, chlamydial hsp60 antibodies in, 129 gonorrhea in, surveillance for, 64 detection of HPV DNA on external genitalia of males with, 629 Prostitutes. See Sex workers Notification. See Partner notification Protease inhibitors, incidence of trichomoniasis in HIV infection and, 839 Oo Proteinase activity, in bacterial vaginosis, 257 Oral contraceptives, condom use with Psychosocial factors, in vaccination for hepatitis C, in young African American gay men, 449 xy adolescents, 719 Pubic lice, epidemiology of, 292 by HIV-infected vs. non—HIV-infected women, Public health clinic attendees. See Sexually transmitted disease clinic P attendees Papanicolaou test, for trichomoniasis, 694 R Parran Award Lecture, 477, 478 Race/ethnicity. See also African Americans Partner ag chlamydia and gonorrhea in incarcerated women and, 64 in discordant adolescent sex partnerships, 234 concordance between sexual behavior and sexual identity and, 110 STD prevalence in adolescent girls and, 211, 214 (editorial), 234 emergency-department screening in inner city vs. urban sites and, 143 Partner notification STD prevalence among urban day laborers and, 661 barriers to, 90 (editorial) Reactor grids, in syphilis surveillance, 650 for chlamydial infection, genotyping and, 205 Rectal gonorrhea, risk factors for, HIV status and, 813 for HIV and syphilis, effects of on sexual behaviors and relationship Reporting, of male-to-male sexual activity, 526 (letter) stability, 75, 83 Risk behaviors/factors. See also Condom use; Sexual behavior; Substance low coverage for gonorrhea, chlamydial infection, and HIV infection in, use/abuse 490 Patient-delivered therapy, for chlamydial infection, 509 of adjudicated African American adolescents, 634 in cross-border sexual networks, in Hong Kong, 827 Patient education, for HPV infection, 193 discordant sexual partners and, 234 Patient-performed sample collection, for cervicovaginal specimens, 107 306, 769, 880 early-onset douching and, 689 effects of partner notification on, 75, 83 Pelvic inflammatory disease emotional experience of intercourse as, 348 average lifetime cost of, 369 of females in New Independent States of Soviet Union, 680 clinical diagnostic codes for CDC case definition of, predictive value of, heterogeneity of, treatment planning and, 388 866 for HIV infection Penicillin. See also Antibiotics in Brazil, 166 N. gonorrhoeae resistance to changing attitudes toward, 764 in Canada, 896 impact of HAART on, 399, 562, 764 in Cuba, 10, 443 in Madagascar, 262 in India, 523 in Malawi, 183, 185 (letters) in Indonesia, 25, 178 in rural areas, 134 in Spain, 395 in HSV-2 infection, in females, 405 Perianal nodular herpes simplex virus infection, in AIDS, 157 of males with/without regular doctors, 512 Perianal warts, imiquimod 5% cream for, 124 of men who have sex with men, at sex resorts, 909 Peru in pregnant African American teens, 57, 211, 214 (editorial) cost-effectiveness of syndromic management in pharmacies in, stability of, in birth cohort, 818 STD prevention in, for sex workers, 273 in Thailand, 320 Pharmacies, syndromic management in Risk spaces, core group concept and, 825 (editorial) in Peru, 379 Rothenberg, Richard, Thomas Parran Award recipient, 477 in South Africa, 609 Russia Phthirus pubis, epidemiology of, 292 sexual habits and HPV infection in females in, 680 Polymerase chain reaction assay sex workers in for HPV, sampling methods for, 246 injection drug use by, 46 (editorial) microwell-plate—based, for Mycoplasma genitalium, 756 social organization of, 39 Pregnancy in African American teens, older partners and STD prevalence among, S 211, 214 (editorial) Sample collection, cervicovaginal, patient-performed, 107, 306, 769, 880 bacterial vaginosis in Sauna, male-only, gonorrhea and chlamydia screening in, 886 management of, 645 Screening Vol. 30¢No. 12 INDEX OF SUBJECTS for chlamydia enumeration of, in Madagascar, 664 in adolescents, 367 (letter) injection drug use by, in Russia, 46 age range for, 120 male, drug injection and sexual mixing patterns of, 571 in asymptomatic men, ligase chain reaction with/without leukocyte male clients of, behavioral surveillance surveys of, in Hong Kong, 620 esterase test for. See Race/ethnicity participatory mapping for, in Madagascar, 664 in community based mobile clinic, 654, 659 (editorial) screening for gonorrhea and chlamydial infection in, in Indonesia, 671 at male-only saunas, 886 social organization of, in Moscow, 39 risk factor vs. clinically based, 901 sociodemographic dynamics and STDs in, at Mexican-Guatemalan bor- emergency-department, in inner city vs. urban sites, 143 der, 266 for gonorrhea STD prevalence in, in Indonesia, 671 in Indonesian sex workers, 671 STD prevention in, 273 at male-oniy saunas, 886 STD treatment algorithms for, in C6te d'Ivoire, 284 in pregnancy, 728 SIS model, for assessment of intervention scenarios, 388 for hepatitis C, in STD clinic attendees, 340 Smoking, HSV-2 infection and, 405 for Medicaid patients, 723 Soldiers mobile community-based, effectiveness of, 654, 659 (editorial) female, chlamydia prevalence in, 539, 545 (editorial) for Peruvian sex workers, 273 male, HIV-infected, human herpesvirus-8 in fection in, 713 Self-sampling, for cervicovaginal secretions, 107, 306, 769, 880 South Africa Sentinel site surveillance, for chlamydial infection, 20 HIV-1 transmission in, migration and, 149 Sex resorts, for gay men, risk behavior at, 909 syndromic management in, role of community pharmacists in, 609 Sex trade. See also Sex workers Soviet Union, New Independent States of, sexual habits and HPV infection participatory mapping of, in Madagascar, 664 in females in, 680 Sexual activity, male-to-male. See also Men who have sex with men Spain reporting of, 526 (letter) cervical HPV infection in, 788 Sexual behavior. See also Risk behaviors/factors NV. gonorrhoeae resistance to ciprofloxacin in, 395 concordance of with sexual identity, racial/ethnic variations in, 110 seroprevalence among STD clinic attendees in, 876 female adolescent, nonexclusivity in romantic relationships in, 752 urethritis in, etiologic and epidemiologic trends in, 280 of females in New Independent States of Soviet Union, 680 Spatial bridging, in importation of gonorrhea and chlamydia, 742, 750 of older women, 216 (editorial) stability of, in birth cohort, 818 Specimen collection Sexual concurrency, quantitative assessment of, 6 of cervicovaginal secretions Sexual debut, douching and, 689 method preferred by incarcerated women, 306 Sexually transmitted disease clinic attendees self-sampling methods for, 107, 306, 769, 880 female condoms use by, 91 urine, for chlamydial infection, in males, 345 hepatitis C screening in, 340 Spermicides, acceptability and product choice as indicators of use of, 556 hepatitis C seroprevalence and risk behaviors in, : Students. See Adolescents; College students HIV seroprevalence in, 876 Substance use/abuse. See also Risk behaviors/factors Internet use by, 33 by adjudicated African American adolescents, 634 pubic lice in, epidemiology of, 292 HIV prevalence and, in Brazil, 166 risk factors and immunity for hepatitis B in, 914 HIV risk and, changing perspectives on, 764 treatment of symptomatic STDs at, 512 human herpesvirus type 8 infection and, 199 with/without regular doctors, STD burden and risk in, 512 by male sex workers, drug injection and sexual mixing patterns of, 571 Sexually transmitted diseases. See also specific diseases by sex workers, in Russia, 46 (editorial) CDC treatment guidelines for, need for revision of, 528 (letter) Swabs in incarcerated women, epidemiologic study of, 531 (letter) dry, for HPV polymerase chain reaction assay, in males, 246 prevalence of self-collected, for cervicovaginal specimen collection, 107, 306, 769, in pregnant women, in Vanuatu, 362 880 among urban Latino day laborers, 661 Syndromic management prevention of of bacterial vaginosis, with/without HIV-1 coinfection, | Internet information sources for, 15 of male STDs, in China, 327 needs assessment for, in China, 600 role of community pharmacists in in sex workers, 273 in Peru, 379 state policy support for, 614 in South Africa, 609 risk factors for. See Risk behaviors/factors Syphilis screening for. See Screening antibiotic prophylaxis for, 844 syndromic treatment of, in China, 327 declining rates of, AIDS mortality as cause of, 419 transmission dynamics in (Thomas Parran Award Lecture), 478 incubating, azithromycin for, cost-effectiveness of, 502 transmission of, gap length and, 221 mass treatment of, 297 Sexual mixing, spatial bridging and, in importation of gonorrhea and outbreak of chlamydia, 742, 750 (editorial) among men who have sex with men, 872 Sexual networks, cross-border, in Hong Kong, 827 targeting sex partner meeting location for, 53: Sexual partnerships partner notification for, effects of on sexual behaviors and relationship discordant stability, 75, 83 of high-risk adolescents, 234 patient characteristics with male-to-male vs. heterosexual acquisition, in of pregnant African American teens, 211, 214 (editorial) Canada, 310 gap length between, STD transmission and, 221 prevalence of, in pregnant women, in Vauatu, 362 quantitative assessment of, 6 screening for. See also Screening targeting meeting places for, in response to syphilis outbreak, 533 in Medicaid patients, 723 Sex workers surveillance for, reactor grids in, 650 chlamydia prevalence in, in Mexico, 195 syndromic management of, in China, 327 drug-resistant N. gonorrhoeae in, in Indonesia, 178 Syphilis reactor grids, 700 934 INDEX OF SUBJECTS ee eee eT ee en = Urine testing Tanzania for chlamydial infection genital ulcer disease in, etiology and HIV coinfection in, 1i4 acceptability of to adolescents, 850 HSV-2 infection in in males, 345 prevalence of, 187, 588 for gonorrhea, acceptability of to adolescents, 850 risk factors for, 187 vs. self-collected vaginal swab Telephone hotline, in Italy, 707 female military recruits’ preference for, 769 Tetracycline, N. gonorrhoeae resistance to, 10 incarcerated women’s preference for, 306 in Canada, 896 n Cuba, 10, 443 Vv n India, 523 accination n Indonesia, 25, 178 for hepatitis n Spain, 395 hepatitis A/B vs. hepatitis B vaccine for, 859 Thailand, adolescent risk behaviors in, 320 for men who have sex with men, 411, 425, 449, 685 Third world countries. See Developing countries among STD clinic attendees, 914 Thomas Parran Award Lecture, 477, 478 for STDs, acceptability of among college students, 774 Topical microbicide, acceptability of to adolescent girls, 854 ‘aginal discharge Transmission dynamics (Thomas Parran Award Lecture), 478 rapid diagnostic kit for, in Gambia, 483 Treatment, syndromic. See Syndromic management syndromic management of, with/without HIV-1 coinfection, | Treatment adherence, HIV-transmission risk behaviors and, 399 aginal douching Treatment planning, mathematical tools for, 388 early-onset, health beliefs and high-risk behavior and, 689 Trichomoniasis HSV-2 infection and, 405 in HIV infection, associated factors in, 839 reasons for continuing or stopping, 71 Papanicolaou test for, 694 aginal flora prevalence of, in pregnant women, in Vauatu, 362 abnormal. See Bacterial vaginosis treatment of effect of single-use Lactobacillus crispatus capsules on, 568 for sex workers, in Céte d'Ivoire, 284 Vaginal swabs, self-collected, for cervicovaginal specimen collection, 107, in syndromic management of urethritis, in Malawi, 516 306, 769, 880 U Vaginitis, treatment algorithms for, for sex workers, in Céte d'Ivoire, 284 ‘aginosis. See Bacterial vaginosis Ulcers. See Genital ulcer disease ‘alacyclovir, for genital herpes, in suppressive vs. episodic therapy, pa- Uncircumcised males, HSV-2 infection in females and, 405 tients’ preference for, 226, 232 (editorial) Ureaplasma urealyticum urethritis, epidemiologic trends in, in Spain, 280 ‘anuatu, STD prevalence in pregnancy in, 362 Urethral discharge, syndromic management of, in China, 327 Urethritis Ww detection of HPV : DNA on external genitali-aagge el of males with, 629 Warts, anogenital gnoonnogcoocncoaclo.c See Gonorrhea/gonococcal infection 5% imiquimod cream for, 124 nongonococcal frequently asked questions about, 193 chronic, chlamydial hsp60 antibody in, 129 etiologic and epidemiologic trends in, in Spain, 280 i syndromic management of, trichomoniasis treatment in, in Malawi, 516 Young Investigator Award (ASTDA), 477

ebook img

Sexually Transmitted Diseases 2003: Vol 30 Index PDF

11 Pages·2003·3.2 MB·English
by  
#periodicals #sim_microfilm #pub_sexually-transmitted-diseases
Save to my drive
Quick download
Download
Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Sexually Transmitted Diseases 2003: Vol 30 Index

index to Volume Thirty Index of Issues: January, 1-98: February, 99-186; March, 187-272; April, 273-368; May, 369-476; June, 477-532 ; July, 533-592; August, 593-670; September, 671-735; October, 737 802; November, 803-870; December, 871-934. . INDEX OF AUTHORS Brown C, 575 Cuesta M, 280 Fortenberry JD, 49 Abel M. 362 Brown DR, 246 Foxman B, 216, 750 Abraham CD, 549 Brown P, 689 D Fox TL, 124 Abrahamowicz M, 581 Brunham RC, 297 Dallabetta G, 664 Franco E, 581 ACSAG Investigators. 6 Buchanan K, 273 Dan M, 794, 835 Fredlund H, 205 Adams AL. 764 Bull SS, 15 Davies SC, 671 French PP, 433 AAAdhdlIaemmr asn B .E JK,8, 7 43 17194 BBBuuurrrkkm haanRr Dd,t W J5,G7, 5 369694 dDDeee em lbasTa S ,C uEe,4 v1a498s 3 C, 395 FFurcihesd maFnD , H,1 663 06, 531 Ahmed HJ, 114 Butler N, 609 De P, 497 Fuchs SC, 166 Funkhouser E, 689 Alarcon J, 273 de Sanjose 3; lary M. 46 Cc Desmond R, 335 Furuya R, 629 Alcald B. 395 acho J, 395 Detels R, 327, 411, 803 G 1l exander L. 193 ‘allahan DB, 340, 645 De Vuyst H, 137 Gala P, 335 Almirall R. 788 aalmvpebt elHl, 4P,9 3 Diamond C, 425 Gallinelli A, 707 Alter MJ, 340 Diao J, 600 Amestoy GM, 5< 93 aimmpp¢o s PE. +e 2 3 Diaz M, 788 Garcia MJ, 280 Amida X, 664 rel D, 174 DiCello AC, 246 Garcia PJ, 379 Anderson JE. 719 arrehoF , 280 Dicker LW, 472 Garin CA, 756 Ande1.r son K, O191 RARRaR rrAiRlRlAoC D. P2D73 Dickson N, 818 Garland S, 362, 886 Anderson LA. 30 ( arvalho SE, 694 DiClemente RJ, 57, 211, 449, 634, Garnett GP, 149, 379 Anoma CK, 284 ( asey_ S, 877A4 909 Gaydos CA, 64, 306, 539, 769 Antolin I, 395 ( asper C, 713 Dilley J, 331, 874, 919 Gaydos JC, 539, 769 Antonio MAD ( astellanos S, 195 Dillon J-AR, 443 Geisler WM, 160 Apter D. 120 ( astle PE, 575 Donegan E, 905 Ghys PD, 284 Aral SO, 39 ( atala I, 788 Dorst D, 75 Gift TL, 502 Armenian HK, I! ( elentano DD. 185 Douglas JM, 562 Gilbert BC, 719 Aronson N, 713 ( hagas C, 694 Douglas JM Jr, 15 Gilbert LK, 193 Arreaza L, 395 ( haowanachan T, 320 Douglas W, 411, 685 Gillespie B, 216 Morrow ( haw JK. 509. 661 Downs J, 71 Gilroy C, 129 ( hemeris G, 680 D’Souza G, 872 Ginocchio RHS, 99 ( hen R, 600 Dutro SM, 756 Girasek DC, 531 ( hen S. 362. 609 Girolomoni G, 157 ( hernesky M, 345, 880, 905 Gisselquist D, 183 Bachmann LH, 20, 3 ( herpes TL, 405 Eckert LO, 357 Gittelsohn J, 149 Biickman A, 205 ( hesson HW, 419 Edmunds WJ, 379 Baker MA, 650 ( hilongozi D, 516 Egger M, 129 Glezerman M, 835 Bala M, 523 ( hiossi G, 707 Ellen JM, 234 Gmach RD, 440 Bandama C, 284 ( hoi K-H, 91 Engelberg R, Golden MR, 490, 742 Barcellos NT. 166 ( hong S, 345 Ennis DM, 512 Goldie SJ, 369 Barivelo I 604 ( hrisnadarmani VAMA, 671 Erokhina O, 680 Gollub EL, 433 Bass DC ( hristensen NO. 262 Escoffery © 315 Gomez CA, 91 Becker 6 ( hu B-C, 614 Espinosa E, 292 Gooding E, 483 Begley E, 211 iaffi L. 671 Esquivel CA, 195 Goossens H, 25 Behets I iesielski CA. 650 Essex M, 187 Goossens W, 25 Beltrami JI intorino M, 680 Essien EJ, 110 Gotuzzo E, 273 n SM laeys P, 137 Esteban JI, 470 Gourley PJ, 399 lark R, 839 Esteban R, 470 Greenland S, 411 -rn) stFeMi,n 7KT5,2 199 ocuroccia B, 15 Ethier K, 809 Gregorich SE, 91 ohen DA, 844 Ettiégne-Traore V, 284 Gregson S, 779 R. 866 ohen MS, 516 Ezcarzaga MLB, 195 Grenfell BT, 388 lford JM, 502 ohn DL, 399 F Grewal N III, 530 BBBlolaeezhjenase nr ¢ D I ooynnenn edlelR- GAl,e zF A1,0 C79J 9, 266, 549 -‘aaiirrlcehyo k CKM,P , 88690 1 GGrriicnes teAa,d 3O6,2 91 Boe onnolly C, 1, 241 ‘alk L, 205 Grosshans JF, 193 ‘arley TA, 75, 654, 839, 844 Grujnberg A, 680 Boerma JT yplan PM, 246 Grujnberga V, 680 Bolan G , Corey | 174, 425, 713 “awzi WW, 187 Guan J, 803 Borrell N osgrove Sweeney YT, 568 Feij6 G, 694 Bosch FX osta MC, 581 Feldblum PJ, 440 Guardia J, 470 Boselli F, 707 osta PL, 694 Fenton J, 33 Gubinelli E, 157 Boskey ER, 107 ourtoisB , 273 Fernandez-Esquer MI Guerino C, 114 Bowen AM, 57 raig T, 83 Fernandez I, 809 Gunnarsson E, 114 Branovskaja M. 680 ranston B, 5 5 Fichtenberg CM, 825 Gunn RA, 340, 645 Brennan CH, 34( Crosby RA, 57 . 211, 634, 909 Fife KH, 246 Gutierrez AA, 195 Brewer T. 914 CruNF,m 7 13 Flaks RC, 399 Gutierrez L, 273 Brodine S, 545. 7 Cruz-Valdez A, 549 Font R, 788 Guzman D, 10 926 INDEX OF * AUTHORS Sexually Transmitted Diseases ¢ December 2003 H Juschenko A, 680 Lind I, 178 Miller JM Jr, 728 Haikala O, 737 Lipova E, 680 Miller WC, 516 Hale S, 901 K Lister NA, 886 Mills J, 232 Hammer GP, 919 Kahn RH, 654, 700, 844 Liu H, 327 HHaanndcshfairedl d B,H H5 75 49. 490. 742 KKKaaalprdiiogmra SJSS,HA ,,3 621 18479 LLil anXe,s 32R7, 10, 443 MMiinnndiesl AAM , 5: HHaartdzieclkl TJ,, 6444 0 Karwalajtys T, 880 LLlloovpe raAs, 1B0,, 748483 MMiknaoyr a-PM, wa72m3b uri D, 149 HHaayweess PS, E,8 863 5 KKaauutna inKe, n 36H2, 737 LLooebbo LT,T ,8 7649 4 MMoodeenscihtt TSRK,, 170674 Kaydos-Daniels SC, 516 Hebb JK. 756 Lolis S, 844 Moncada J, 575, 905 HHHHHeeeeeerrrcsnnnk aaamnnnaPddSdne,ee z zz- (-1T M0GM7,aT a,r sqt1ue36le46lz a nlo sC, 5A 49 2~ 66 KKKKKeeeeaenlnzltlne oymg CKbgKB eG,, E ,T AP45,97N ,1, 7] 536335 131,1 6, 913968 . 813 LLLLLoooooruvnwiiednaelnd eeesrDssB ,, M5MC3S9O3M3,1,, , 19744 1639 MMMMMooooorronriadresnlono eeony J SJK,L, ,P W ,,55 942 3188, 38 52041 Herrera L, 593 Kerani RP, 742 Lumpkins J, 335 HHHHHiieoolrrbfloribfseesmrer a on SM 1L,RM ,,I 6F, 2 57919,3 5 5,11 662 5778 Pal KKKKKiiiiilsplmps m iiaknEra,gAx reA ir5, 1P6RH 8P,,,1 3 14293,02 0 75, 214, 731, 839 LLMuyarocinaesl uMsENoE ,, M,13 04 9M2 0 MMMMMMuoousscssugoheuyawilrabroee ioyy aS DELPJ,K,,, E E ,,651 408375978621 5 64 HHHooolgmmbaeensn RKMKK,, , 4492047,03 74+4432 / 9 190) KKliawueslnu6e 6r1 ,I E,J D8.1 138,7 3 318.7 4, 3698.1 9 509. 609. MMaafcac KKeEi,l nlna3or2 7n D,S , 482850 MMuulndoezr NP,G H5,9 3,6 3798 8 Hook 8E50W Il, 20 335 369 Sl KKllejtuekri naB , | 137O SU MMaaggindu s DJ,M , 3705 , 731, 839 MMuurrirlalyo PPJ,, 437400 Hoover DR, 433 Kobayashi I, 629 Maher JE, 75, 83 Myers L, 75, 839 Horner P, 129 Koenig L, 809 Mahony J, 345 N Hotta H, 629 Kohl K, 650 Majkowski JM, 854 National Gonococcal Surveil- Howard M SRO Koroku M 629 Manongi R, 187 lance Program Members, Howell MR, 539, 769 Koumans EH 700 Margolis HS, 340 896 Howe SR 4 Kozachenko V, 680 Marina RB, 226 National Institute of Mental Hoxworth T, 83 Krantz E, 174, 310 Markowitz LE, 49, 320, 650, 700 Health Collaborative HIV HHusgiheehs J,Y- H, 2736,4, 77566‘ ) KKrriasuttj-aBnescshoenr M,J R, 24292 1 MMaarrtrealzl zoM , JM4,7 0 99, 890 P80r3e vention Trial Group, Hu L, 803 Krohn MA, 405 Martin DH, 49, 844 Neilsen GA, 671 Hultunen-Back | 3 Krunfly C, 593 Martinez I, 10 Nelson MB, 306 Humblet O, 818 Kruse N, 664 Martin I, 896 Nerovjna R, 680 Hussain A, 588 Kumamoto Y 629 Martinko T, 901 Ness RB, 71 Hutapea N, 178 Kumari S, 523 Martinson F, 516 Newman SB, 306, 531 Hutchinson ML, 57 Kumwenda N, 185 Masenga EJ, 187 Ng L-K, 896 Kunishima Y, 629 Mastro TD, 320 Niccolai LM, 75 I Kus J, 64 Matos E, 593 leven M, 25 Maupin RT, 728 Niesters HGM, 639 Nikitina M, 680 Irwin K, 30, 866 Maurice CE, 284 Ivanchenko O, 680 ackey PC, 512 Mayaud P, 483 Nishimura M, 629 Iwasawa A, 629 aga M, 284 Mayberry R, 723 Nsuami M, 367, 728 agergard T, 114 Mbizvo E, 588 Nyamukapa C, 779 J Lammens C, 25 Mbwana J, 114 Oo Jacobson LP, 199 and DJ, 348 McClure M, 129 O’Brien ME, 731 JJJaaancmgoi bssoD n, RJ3D.4 .5 ,8 532987 8 0 aanintpgie druoDs , MJ5IA7,, 71604 MMccFFaarrllaanned MW,, 3153 1, 609, 919 OOhk saMnKe,n 4H9,, 162809 Jansen KU, 246 atka M, 433 MMccGKeeee ZKAT, Jr5,3 05 39, 769 Olafsson JH, 249 Jayaraman GC, 315 au A, 896 McLean CA, 650 OOl'cLéena ryP , M2,0 5 362 Jeansson S, 588 au JTF, 600, 620, 827 Medland NA, 886 Olmsted SS, 257 Jeeyapant S, 320 azcano-Ponce E, 549 Medrano JC, 195 Osterhaus ADME, 639 JJJJJeeooonnhhhknanniinssnnsoosgsnn so nF GJSJ,,, M B,8,61 3 59 4962, 83 04 844 LLLLLaeeeezeeehz maJJaMrHKo,n,,t t8o82J0 73S3,24 T,7 6145 7 MMMMMeeeeeirhrhjttceezahur as n GStCJD ,JA, ,L JM8, 20,16154 839 5 93, 788 OOOOttvwteaeorsn oks aB ,iL ,nM 6eL7n2,18 0,O 1T2,249 2,3 883 95 Johnson SM, 533 Le Pont F, 6 Mestad RE, 728 P Jolley L, 193 Leutscher PDC, 262 Mettey A, 909 Paavonen J, 120, 737 Jones M, 335, 850 Levine D, 634 Meyerhoff AS, 859 Padian NS, 556 Jénsdoéttir K, 249 Levine WC, 472 Meyers M, 134 Paffel JM, 872 Jordan N, 723 Liang G, 803 Meyerson BE, 614 Page-Shafer K, 331, 919 Judrez-Figueroa L, 266 Li H, 443 Meyn LA, 257, 405 Pajanidi J, 680 Judson FN, 562 Li L, 803 Mhalu F, 114 Palacio V, 280 Junquera ML, 292 Limones DEC, 195 Michaud JM, 533 Palefsky JM, 575 Jurstrand M, 205 Lindberg M, 205 Migliani R, 262 Palma S, 10 INDEX OF * AUTHORS 927 Parker KA, 39 Rosana Y, 25 Stamm WE, 160, 357 van der Snoek EM, 639 Partohudoyo S, 671 Rose E, 57, 211, 634 Stanberry LR, 752, 801, 854 van Doornum GJJ, 639 Patel D, 216 Rosenthal SL, 752, 774, 801, 854 Steingrimsson O, 249 Van Dyck E, 284 Patnaik JL, 15, 562 Ross MW, 110 Stein ZA, 433 Van Griensven F, 320 Patten J, 671 Rothenberg R, 478 Stephan K, 713 Van Looveren M, 25 Patton DL, 568 Rotheram MJ, 803 Sternberg M, 49, 320 Vanmali T, 241 Paukku M, 120 Rothman RE, 143 Steyaert S, 137 Van Marck E, 137 Paul C, 818 Rousseau M-C, 581 Stiffman M, 30 Van Renterghem L, 137 Paz-Bailey G, 320 Rousset D, 262 Stine K, 890 Vansteelandt S, 137 Pech N, 6 Ruben M, 443 Stray-Pedersen B, 588 Perdue T, 425 Rudy E, 411, 685 Strickler HD, 575 Vaovola G, 664 PPeettreorvmiacnh ev TA,N , 756,8 0 83, 73 RRuusutt u G,P , 72733 7 SSttruirnme TA,W ,6 85 1, 149, 24] VVaarzeqluae z JAF,, 228800,, 229922 , 395 Pettifor A, 455 Ryan CA, 39 Sturm PDJ, 241 Vazquez JA, 395 Pfister JR, 797 Succop PA, 752 Veenstra DL, 99 Pigott D, 335 S Suchland RJ, 160, 357 Villa LL, 581 Platt L, 46 Sadan O, 835 Sudigdoadi S, 25 Villar H, 395 Platt R, 866 Safarova E, 39 Sugai K, 575 Vlahov D, 199 Podistov J, 680 Sahin-Hodoglugil NN, 455 Su L, 246 Vuylsteke BL, 284 PPootutmerearto l JJ,G ,8 9,3 624 90 SSaalkaas TE,V ,6 291 95 SSuulplaiwviatnk ulE A, S, 36322 0 W Pourbohloul B, 297 Salcedo C, 395 Sutama IN, 671 Wald A, 174, 310, 713, 890 Preiksaitis J, 33 Sam NE, 187, 588 Sutton TL, 901 Wallace MR, 713 Price MA, 516 Samra Z, 794, 835 Su X, 178 Walsh J, 455 Primary Care STI Study Group Samson ET, 671 Svensson LA, 114 Walter E, 809 (GITSAP), 876 Sanchez C, 280, 292 Sweat MD, 149 Waltje A, 134 Prince MA, 593 Sanchez J, 273 Wang Q, 600 Proyecto Concordia Collaborative Sanchez-Zamorano L, 549 SSywrejeati neRn L, K, 716 80 Wang SA, 528 Group, 593 Sanders WM, 512 Syrjiinen S, 680 Ward K, 609 Pshepurko A, 680 Sansom S, 685 T Watts D, 273 Puolakkainen M, 120 Santelli J, 719 Wegner S, 713 Santopietro R, 680 Tabrizi S, 362, 886 Weinberg M, 645 Q Satcher D, 723 Taha TE, 185 Weisbord JS, 914 QQQuuuieinrnt n J,WT ,C4 ,7 01 3573 9, 769 SSaauucdae r G,D N,3 95 124 Tlaakkaehyaasmhia SK,, 662299 WWeeissts B,H L,4 838 50 Schachter J, 575, 905 Taleo H, 362 Whelan M, 866 R Schaffzin JK, 700 Tambis JA, 661 Whitten KL, 348 Rabe LK, 568 Scherf E, 794 Tanda H, 629 Whittington WLH, 49, 160, 742 Ramarokoto C-E, 2 Schiffman M, 575 Tang Y, 866 Wiktor SZ, 284 Ramirez-Arcos S, Schillinger JA, 49 Tao G, 866 Wilkinson D, |, 241 Ramos BPL, 195 Schim van der Loeff M, 483 Tapsall JW, 178 Williams BG, 149 Ransom RL, 49 Schwarcz S, 609 Tasker SA, 713 Williams I, 919 Raphael TL, 614 Seattle Young Men’s Survey Team, Tawes J, 64 Williams ML, 110, 571 Ratelle S, 866 425 Taylor-Robinson D, 129 Wilson TE, 809 Rattray C, 575 Secura GM, 425 Temmerman M, 137 Wingood GM, 57, 211, 634 Ravaoalimalala EV. 262 Sellors J, 345, 880 Terndrup T, 335 Wong E, 331, 919 Raveh D, 835 Shabalova I, 680 Thiede H, 425 Wong T, 497 Ray K, 523 Shafer M-A, 545 Thomas AG, 713 RReegaido naRlR , In3f1e5r tility Prevention Pro SShhaakoa riJsF,h vi1l8i7 A, 39 TThiokmhaonso vaB , L1,2 9 39 WWooondgc oWx, V6,6 1 880 gram, 472 Shiboski SC, 556 Timpson S, 571 Woods R, 455 Workowski KA, 528 Rein MF, 348 Shimizu T, 629 Tosi P. 680 Rekart ML, 297 Short MB, 752, 854 Totten PA, 756 Wu Z, 803 Renjifo B, 187 Siddiqi O, 262 Irepka MJ, 914 xX Reppucci ND, 348 Silverthorn M, 134 Tsidaeva I, 680 Xavier J, 694 Reunala T, 737 Sim6es-Barbosa A, 694 Tsui H, 600, 620 Rhodes SD, 449 Simpson T, 689 Tsukamoto T, 629 Y Rice P, 71 Sinclair MF, 650 Tulloch S, 64 Yacoub W, 497 Richardson-Alston G, 75, 731 Singh A, 315, 497 Turkheimer E, 348 Yarber W, 134 Richardson E, 880 Sitati S, 137 Turner KR, 331 Yeh JM, 369 Richter HE, 71 Sizemore JM, 512 U Yin Y, 327, 803 Rietmeijer CA, 15, 399, 562, 659 Skinner RB, 124 Urassa M, 779 Yokoe D, 866 Rinaldi J, 874 Smith A, 886 Uribe-Salas F, 266 Yuan W, 600 Roberts CM, 797 Snijders PJF, 788 Roberts JN, 226 Soper DE, 71 \ Z Rogers C, 433 Sosa J, 10, 443 Valdés EA, 10 Zakharenko S, 680 Rohan LC, 257 Sozaeva L, 680 Valleroy L, 425 Zakharova T, 680 Rohan TE, 581 Spear SJ, 797 Valtrex HS230017 Study Group, Zenilman JM, 143 Rojas C, 246 Spencer NE, 83 226 Zhang G, 914 Romanowski B, 33, St. Lawrence JS, 39, 490 van den Brule AJC, 593 Zimba D, 516 Stamm C, 71 van der Meijden WI, 639 Zuma K, 149 Sexually Transmitted Diseases ¢ December 2003 INDEX OF SUBJECTS A Army recruits Acquired immunodeficiency syndrome. See Human immunodeficiency vi- female, chlamydia prevalence in, 539, 545 (editorial) rus infection male, HIV-infected, human herpesvirus-8 infection in, 713 Adjudicated African American adolescents, risk behavior of, 634 ASTDA awards, 477, 478 Adolescents Australia, gonorrhea and chlamydia screening in, at male-only saunas, 886 acceptability of urine screening for gonorrhea and chlamydia in, 850 Azithromycin adjudicated African American, risk behavior of, 634 for chlamydial infection, partner-delivered partner treatment with, 49 dual use of condoms and hormonal contraceptives by, 719 for incubating syphilis, cost-effectiveness of, 502 female N. gonorrhoeae resistance to, in Cuba, 443 nonexclusivity in romantic relationships of, 752 B topical microbicide use by, 854 Bacterial vaginosis genital herpes in, HSV type | as predominant cause of, 797 glycosidase and proteinase activity in, 257 high-risk, discordant sexual partnerships of, 234 HSV-2 infection and, 405 HSV-2 infection in, sexual and demographic risk factors for, in Mexico, in pregnancy, management of, 645 549 rapid diagnostic kit for, in Gambia, 483 pregnant African American syndromic management of, with/without HIV-1 coinfection, | continued risky sex among, 57, 211, 214 (editorial) treatment algorithms for, for sex workers, in Céte d’Ivoire, 284 with older partners, STD prevalence among, 211, 214 (editorial) Barrier contraceptives. See also Condom use risk behaviors of, in Thailand, 320 acceptability and product choice as indicators of use of, 556 screening recommendations for, 367 (letter) Bathhouses, male-only, gonorrhea and chlamydia screening in, 886 Africa. See also specific countries Belarus, sexual habits and HPV infection in females in, 680 bacterial vaginosis in Birth control pills, condom use with rapid diagnostic kit for, 483 by adolescents, 719 treatment algorithms for sex workers in, 284 by HIV-infected vs. non—HIV-infected women, 809 cost-effectiveness of diagnosis and treatment protocols for chlamydia Brazil, HIV risk factors and prevalence in, 166 and gonorrhea in, 455 Bridge members, of adolescent sexual networks, 234 genital ulcer disease in, etiology and HIV co-infection in, 114 HIV-1 transmission in, migration and, 149 Cc HIV prevalence in, 183, 185 (letters) Canada HIV risk factors in, 183, 185 (letters), 262 gonorrhea outbreak in, 497 HPV distribution in family planning clinic attendees in, 137 N. gonorrhoeae drug resistance in, 896 HSV type 2 infection in syphilis outbreak in, patient characteristics with male-to-male vs. het- prevalence of, 187, 588 erosexual acquisition in, 310 risk factors for, 187, 262 Candidal vaginitis, treatment algorithms for, for sex workers, in Cote participatory mapping of sex trade in, 664 d'Ivoire, 284 sex workers in, STD treatment algorithms for, 284 Capture-recapture methodology, in sex trade mapping and sex worker syndromic management in, role of community pharmacists in, 609 enumeration, in Madagascar, 664 uneven HIV prevalence in, 779 Caribbean, drug-resistant N. gonorrhoeae in, 10, 443 African Americans. See also Race/ethnicity CDC case definition, of pelvic inflammatory disease, predictive value of adjudicated adolescent, risk behavior of, 634 clinical diagnostic codes for, 866 gay, hepatitis B vaccination in, 449, 685 Centers for Disease Control and Prevention (CDC), treatment guidelines of pregnant adolescent for chlamydia, adherence to in managed care organizations, 30 continued risky sex among, 57 need for revision of, 528 (letter) with older partners, STD prevalence among, 211, 214 (editorial) Cervical gonococcal infections, in Indonesian sex workers, 671 Age Cervical neoplasia grade, STD coinfections and, in Jamaica, 575 cervical infection with multiple HPV types and, 581 Cervicovaginal secretion collection, self-sampling methods for, 107, 306, female, condom use and, 216 769, 880 partner China. See also Hong Kong in discordant adolescent sex partnerships, 234 market vendors in, STD prevalence and characteristics in, 803 STD prevalence in adolescent girls and, 211, 214 (editorial), 234 STD/HIV prevention in, needs assessment for, 600 AIDS. See Human immunodeficiency virus infection syndromic management of male STDs in, 327 Anal nodular herpes simplex virus infection, in AIDS, 157 Chlamydial heat-shock protein 60 KDA antibodies, 157 Anal warts, imiquimod 5% cream for, 124 in chronic nongonococcal urethritis, 129 Anogenital warts Chlamydial infection 5% imiquimod cream for, 124 adolescent risk behaviors and, in Thailand, 320 frequently asked questions about, 193 CDC guidelines for, adherence to in managed care organizations, 30 Antibiotics cervical neoplasia grade and, in Jamaica, 575 prophylactic, for syphilis, 844 cervicovaginal specimen collection for, self-sampling methods for, 107 topical, acceptability of to adolescent girls, 854 306, 769, 880 Antimicrobial resistance, of N. gonorrhoeae contact tracing for, genotyping and, 205 in Canada, 896 cost-effectiveness of diagnosis and treatment protocols for, in Africa, in Cuba, 11, 443 455 in India, 523 gonococcal coinfection and, in young women, 472 in Indonesia, 25, 178 HPV infection and, in men who have sex with men, 639 in Spain, 395 importation of, spatial bridging in, 742, 750 (editorial) Antiretroviral therapy in incarcerated women adherence to, transmission risk behaviors and, 399 preferred sampling methods of, 306 availability of, impact of on risk behaviors, 562, 765 surveillance for, 64 Argentina, HPV infection in, prevalence of in females, 593 increased incidence of, in Finland, 737 INDEX OF SUBJECTS 929 male, epidemiologic trends in, in Spain, 280 acceptability and product choice as indicators of use of, 556 molecular epidemiology of, in Iceland, 249 oral, condom use with partner notification for, low coverage of, 490 by adolescents, 719 patient-delivered partner therapy with azithromycin for, 49 by HIV-infected vs. non—-HIV-infected women, 809 patient-delivered therapy for, 509 Core groups in pregnant African American teens with older partners, 211, 214 (edi- geographic stability of, 825 (editorial) torial) stability of sexual behavior in, 818 prevalence of Correspondence, 183, 185, 367, 368, 526, 528, 531 n female Army recruits, 539, 545 (editorial) Cost, average lifetime, of pelvic inflammatory disease, 369 n female emergency department patients, 335 Cost effectiveness in Finland, 737 of azithromycin, for incubating syphilis, 502 in Indonesian sex workers, 671 of diagnosis and treatment protocols for chlamydia and gonorrhea, in in Mexican sex workers, 195 Africa, 455 in pregnant women, in Vauatu, 362 of syndromic management in pharmacies in ROTC cadets, 901 in Peru, 379 eening for. See also Screening in South Africa, 609 in adolescents, 367 (letter) age range for, 120 Cote dIvoire, treatment algorithms for bacterial vaginosis in sex workers in asymptomatic men, ligase chain reaction with/without leukocyte in, 284 Counseling, telephone, in Italy, 707 esterase test for, 99 in community based mobile clinic, 654 Cross-border sexual networks, in Hong Kong, 827 in Indonesian sex workers, 671 Cuba, drug-resistant N. gonorrhoeae in, 10, 443 at male-only saunas, 320 D risk factor vs. clinically based. 901 Day laborers, urban immigrant, STD prevalence among, 661 sentinel site surveillance for, 20 Detained African American adolescents, risk behavior of, 634 serovar-clinical manifestations correlation in, 160 Developing countries. See also specific countries syndromic management of, in China, 327 adolescent risk behaviors in, 320 urine testing for in males, 345 bacterial vaginosis in self-sampling methods for, 306, 769 rapid diagnostic kit for, 483 treatment algorithms for sex workers in, 284 hlamydia trachomatis genotyping of, contact tracing and, 205 cost-effectiveness of diagnosis and treatment protocols for chlamydia serovars of, longitudinal assessment of, 357 and gonorrhea in, 455 Cigarette smoking, HSV 2 infection and, 405 drug-resistant N. gonorrhoeae in, 10, 178, 443 Ciprofloxacin, gonococcal resistance to. See also Antimicrobial resistance genital ulcer disease in, etiology and HIV co-infection in, 114 in India, 523 HIV-1 transmission in, migration and, 149 in Spain, 395 HIV prevalence in, 183, 185 (letters) Circumcision, HSV-2 infection in females and, 405 HIV risk factors in, 187, 262 Clinic attendees. See Family planning clinic attendees; Sexually transmit HPV distribution in family planning clinic attendees in, 137 ted disease clinic attendees HSV type 2 infection in College students. See also Adolescents prevalence of, 187, 588 acceptability of STD vaccination in, 774 risk factors for, 187, 262 genital herpes in, HSV type | as predominant cause of, 79 laboratory testing for STDs and HIV infection in, 905 Commercial sex workers. See Sex workers N. gonorrhoeae antimicrobial susceptibility in, 25, 178 Community-based screening, effectiveness of, 654. 659 (editorial) participatory mapping of sex trade in, 664 Community pharmacists, as treatment providers rapid diagnostic kit for bacterial vaginosis in, 483 in Peru, 379 sexual partnership and concurrency in, quantitative assessment of, 6 in South Africa, 609 sex workers in Compliance, with antiretroviral therapy, transmission risk behaviors and, sociodemographic dynamics and STDs in, 266 399 STD treatment algorithms for, 284 Concurrency, quantitative assessment of, 6 STD prevalence in pregnancy in, 362 Condom use. See also Risk behavior/factors STD prevention in, for sex workers, 273 acceptability and product choice as indicators of, 556 syndromic management in, role of community pharmacists in, 609 by adjudicated African American adolescents, 634 syndromic management in pharmacies in, 379, 609 female condoms syndromic management of male STDs in, 327 icceptability and product choice as indicators of, 556 uneven HIV prevalence in, 779 patterns and predictors of, 91, 556 Diagnostic testing, in developing countries, 905 use-effectiveness of, 433, 440 (editorial) by HIV-infected persons, in rural areas, 134 Discordant sexual partners with hormonal contraceptives of high-risk adolescents, 234 by adolescents, 719 of pregnant African American teens, 211, 214 (editorial) by HIV-infected vs. non—HIV-infected women, 809 Douching by older women, 216 early-onset, health beliefs and high-risk behavior and, 689 promotion of, in China, 600 HSV-2 infection and, 405 by sex workers, in Peru, 273 reasons for continuing or stopping, 71 Condylomata acuminata Drug resistance. See Antimicrobial resistance frequently asked questions about, 193 Drug use. See Substance use/abuse imiquimod 5% cream for, 124 Dry swab sampling Contact tracing. See Partner notification for HPV polymerase chain reaction assay, in males, 246 Contraceptives self-performed, for cervicovaginal specimen collection, 107, 306, 769, barrier. See also Condom use 880 930 INDEX OF SUBJECTS Sexually Transmitted Diseases ¢ December 2003 E trichomoniasis treatment in, in Malawi, 516 Economic factors. See under Cost treatment algorithms for, for sex workers, in Céte d'Ivoire, 284 Editorials, 10, 46, 90, 214, 232, 440, 659, 750, 801, 825 urine testing for, acceptability of to adolescents, 850 Education, patient, for HPV infection, 193 Guatemala, sex workers in, sociodemographic dynamics and STDs in, 266 ELISA, time course to seroconversion by, in HSV-1 infection, 310 Emergency department patients, female, gonorrhea and chlamydia preva- H lence in, 335 Health-seeking behavior, of male STD clinic attendees with/without reg- Emergency-department screening, in inner city vs. urban sites, 143 ular doctors, 512 Ethnicity. See Race/ethnicity Hepatitis, vaccination for, hepatitis A/B vs. hepatitis B vaccine for, 859 Hepatitis A, in men who have sex with men prevalence of, 425 Family planning clinic attendees risk factors for, 425 female condom use among, 91 vaccination for, 411, 425, 685, 859 HPV distribution in, 137 Hepatitis B Female condoms. See also Condom use in men who have sex with men acceptability and product choice as indicators of use of, 556 prevalence of, 425 patterns and predictors of use of, 91, 556 risk factors for, 425 use-effectiveness of, 433, 440 (editorial) vaccination in, 411, 425, 449, 685, 859 FemExam, for bacterial vaginosis, 483 risk factors and immunity for, in STD clinic attendees, 914 Financial factors. See under Cost Hepatitis C Finland, chlamydial infection in in men who have sex with men, 425 increased incidence of, 737 screening for, in STD clinic attendees, 340 screening for, 120 seroprevalence of and risk behaviors for, in STD clinic attendees, Fluoroquinolones, resistance to. See also Antimicrobial resistance sexual transmission of CDC treatment guidelines and, 528 (letter) after IUD removal, 470 rates of, 919 G HerpeSelect ELISA, time course to seroconversion by, in HSV-1 infection, Gambia, rapid diagnostic kit for bacterial vaginosis in, 483 310 Gap length, STD transmission and, 221 Herpes simplex virus infection Gays. See Men who have sex with men genital ulcer disease as, in Tanzania, 114 Genital herpes. See Herpes simplex virus infection HPV infection and, in men who have sex with men, 639 Genital ulcer disease, 124 nodular perianal, in AIDS, 157 HIV coinfection and prevalence of and risk factors for, in lesbians, 890 in Tanzania, 114 suppressive vs. episodic treatment for, patients’ preference for, 226, 232 treatment response and, 241 (editorial) HSV-2 as etiologic agent of, in Tanzania, 114 type | syndromic management of, in China, 327 in college students, 797 Genital warts in first episode, 801 (editorial) frequently asked questions about, 193 in Israel, 794 imiquimod 5% cream for, 124 natural history of, 174 Geographic stability, of core groups, 825 (editorial) time course of seroconversion by ELISA in, 311 Glycosidase activity, in bacterial vaginosis, 257 type 2 Gonorrhea/gonococcal infection cervical neoplasia grade and, in Jamaica, 575 adolescent risk behaviors and, in Thailand, 320 in persons seeking repeat HIV testing, 33 chlamydia coinfection in, in young women, 472 in pregnant Israeli women, 835 detection of HPV on external genitalia of males with, 629 prevalence of, in Tanzania, 187 drug-resistant risk factors for in Canada, 896 in females, 405 in Cuba, 11, 443 in Mexican adolescents and young adults, 549 in India, 523 in Tanzania, 187 n Indonesia, 25, 178“a Highly active antiretroviral therapy in Java, Indonesia, adherence to, transmission risk behaviors and, 399 in Spain, 395 impact of on risk behaviors, 399, 562, 764 etiologic and epidemiologic trends in, in Spain, 280 Hispanic day laborers, urban, STD prevalence among, 661 HPV infection and, in men who have sex with men, 639 HIV infection. See Human immunodeficiency virus infection importation of, spatial bridging in, 742, 750 (editorial) Homosexuals. See Lesbians; Men who have sex with men in incarcerated women, surveillance for, 64 Hong Kong. See also China outbreak of, in northern Alberta, Canada, 497 behavioral surveillance surveys of male clients of female sex workers in, partner notification for, low coverage of, 490 620 prevalence of cross-border sexual networks in, 827 in female emergency department patients, 335 Hormonal contraceptives, condom use with in Indonesian sex workers, 671 by adolescents, 719 in pregnant women, in Vauatu, 362 by HIV-infected vs. non—-HIV-infected women, 809 in women 15 to 24, 472 Human herpesvirus-8 infection rectal, risk factors for, HIV status and, 813 in HIV-infected soldiers, 700 screening for. See also Screening in injection drug users, 199 in adolescents, 367 (letter) Human immunodeficiency virus infection in Indonesian sex workers, 671 adolescent risk behaviors and, in Thailand, 320 at male-only saunas, 320 anonymous counseling and testing sites for, treatment of asymptomatic in pregnancy, 728 STDs at, 874 syndromic management of counseling and testing sites for, treatment of asymptomatic STDs at, 874 in China, 327 dual contraceptive use and, 809 INDEX OF SUBJECTS 93] HAART for, impact of on risk behaviors, 399, 562, 765 Intrauterine device, hepatitis C transmission after removal of, 470 human herpes type 8 infection and, in soldiers, 700 Intravenous drug use. See Injection drug use mortality in, as cause of declining syphilis rates, 419 Israel nodular perianal HSV infection in, 157 genital herpes in, HSV type | as predominant cause of, 794 partner notification for HSV type 2 in pregnant women in, 835 effects of on sexual behaviors and relationship stability, 75 Italy, telephone hotline in, 707 low coverage of, 490 prevalence of, in Malawi, 183, 185 (letters) J risk behaviors/factors fot Jamaica, cervical neoplasia grade in, STD coinfections and, 575 in Brazil, 166 Java, N. gonorrhoeae antimicrobial susceptibility in, 25 changing perspectives on, 764 K impact of HAART on, 562, 764 Kenya, HPV distribution in family planning clinic attendees in, 137 in Madagascar, 262 Klausner, Jeffrey, ASTDA Young Investigator Award recipient, 477 in Malawi, 183, 185 (letters) in rural areas, 134 L screening for. See Screening Laboratory testing, in developing countries, 905 seropositivity for Lactobacillus crispatus capsules, single-use safety study of, 568 disclosure of by patient 731 atino immigrant day laborers, urban, STD prevalence among, 661 dual condom use by women and, 809 “atvia, sexual habits and HPV infection in females in, 680 risk behaviors for rectal gonorrhea and, 813 esbians, HSV infection in, prevalence of and risk factors for, 890 among STD clinic attendees, in Spain, 876 etters to editor, 183, 185, 367, 368, 526, 528, 531, 531531 symptomatic management of bacterial vaginosis in, | eukocyte esterase test, for chlamydial infection, in asymptomatic males, testing for, perceptions of risk and, 764 99 transmission of, effect of migration on, in South Africa, 149 Lice, pubic, epidemiology of, 292 reatment response in genital ulcer disease and, 241 Ligase chain reaction, with/without leukocyte esterase test, for chlamydial trichomoniasis in, associated factors in, 839 infection, in asymptomatic males, 99 uneven prevalence of, in Africa, 779 iman papillomavirus DNA, detection of on external genitalia of males M with urethritis, 629 Madagascar iman papillomavirus infection HIV risk factors in, 262 participatory mapping of sex trade in, 664 asymptomatic, in males with urethritis, 629 cervical, in Spain, 788 Malawi cervical neoplasia grade in, STD coinfections and, in Jamaica, 575 HIV prevalence and risk factors in, 183, 185 (letters) in family planning clinic attendees, in Kenya, 137 syndromic treatment of urethritis in, trichomoniasis treatment in, 516 frequently asked questions about, 193 Male-to-male sexual activity. See Men who have sex with men with multiple HPV types, age and cytologic abnormalities and, 581 Managed care organizations, adherence to CDC guidelines for chlamydial PCR assay for, sampling methods for, 246 infections in, 30 prevalence of, in Argentine women, 593 Mapping, of sex trade, in Madagascar, 664 Human T-cell lymphotropic virus type |, cervical neoplasia grade and, in Mathematical tocls, for assessing effectiveness of intervention scenarios, 388 Jamaica, 575 Men who have sex with men I gonorrhea and chlamydia screening in, 886 Iceland, chlamydial infection in, molecular epidemiology of, 249 at male-only saunas, 886 Imiquimod 5% cream, for exterrial genital and perianal warts, 124 hepatitis vaccination for, 411, 425, 449, 685, Immigrant day laborers, urban, STD prevalence among, 661 HPV infection in, STD coinfection and, 639 Immunization pubic lice in, 292 for hepatitis risk behaviors of hepatitis A/B vs. hepatitis B vaccine for, 859 availability ofH AART and, 562 for men who have sex with men, 411, 425, 449, 685 in Canadian syphilis outbreak, 315 among STD clinic attendees, 914 at sex resorts, 909 for STDs, acceptability of among college students, 774 self-reported sexual activity of, 526 (letter) Incarcerated persons syphilis outbreak among, 872 \frican American adolescent, risk behavior of, 634 young African American, hepatitis B vaccination in, 449 female Metronidazole, for trichomoniasis, in syndromic treatment of urethritis, in chlamydia in Malawi, 516 preferred sampling methods for, 306 Mexico surveillance for, 64 chlamydia prevalence in, 195 epidemiologic study on STDs in, 531 (letter) HSV-2 infection in, sexual and demographic risk factors for, in adoles- gonorrhea in, surveillance for, 64 cents and young adults, 549 India, ciprofloxacin- and penicillin-resistant N. gonorrhoeae in, 523 sex workers in, sociodemographic dynamics and STDs in, 266 Indonesia urban day laborers from, STD prevalence among, 661 laboratory testing for STDs and HIV infection in, 905 Microbicides N. gonorrhoeae antimicrobial susceptibility im, 25, 178 N. gonorrhoeae resistance to sex workers in in Canada, 896 gonorrhea/chlamydia screening in, 671 in Cuba, 11, 443 STD prevalence in, 671 in India, 52 3~S Injection drug use in Indonesia, 25, 178 HIV prevalence and, in Brazil, 166 in Spain, 395 human herpesvirus type 8 infection and, 199 prophylactic, for syphilis, 844 by sex workers, in Russia, 46 (editorial) topical, acceptability of to adolescent girls, 854 Internet, as information resource, for at-risk populations, 15 Microwell-plate—based PCR assay, for Vycoplasma genitalium, 756 Intervention scenarios, mathematical tools for, 388 Migrant laborers, urban Latino, STD prevalence among, 661 932 INDEX OF SUBJECTS Sexually Transmitted Diseases ¢ December 2003 Military recruits preterm labor and, 645 female, chlamydia prevalence in, 539, 54: (editorial) continued risky sex during, among African American adolescents, $ male, HIV-infected, human herpesvirus-8 in fection in, 713 gonorrhea screening in, 728 Mobile community-based screening, effectiveness of, 654, 659 (editorial) HSV-2 infection in, in Israel, 835 Mycoplasma genitalium, microwell-plate—based PCR assay for, 756 STD prevalence in, in Vanuatu, 362 Preterm labor, bacterial vaginosis and, 645 N Prevention Neisseria gonorrhoeae, antimicrobial susceptibility of Internet information sources for, 15 in Canada, 896 needs assessment for, in China, 600 in Cuba 1] , 443 in sex workers, in Peru, 273 in India 9° 3 State policy support for, 614 in Indonesia, 25, 178 Prisoners in Spain, 395 African American adolescent, risk behavior of, 634 Netherlands, HPV infection in gay men in, STD coinfection and, 639 female New Independent States of Soviet Union, sexual habits and HPV infection chlamydial infection in in females in, 680 preferred sampling methods for, 306 Nodular perianal herpes simplex virus infection, in AIDS, 157 surveillance for, 64 Nongonococcal urethritis epidemiologic study on STDs in, 531 (letter) chronic, chlamydial hsp60 antibodies in, 129 gonorrhea in, surveillance for, 64 detection of HPV DNA on external genitalia of males with, 629 Prostitutes. See Sex workers Notification. See Partner notification Protease inhibitors, incidence of trichomoniasis in HIV infection and, 839 Oo Proteinase activity, in bacterial vaginosis, 257 Oral contraceptives, condom use with Psychosocial factors, in vaccination for hepatitis C, in young African American gay men, 449 xy adolescents, 719 Pubic lice, epidemiology of, 292 by HIV-infected vs. non—HIV-infected women, Public health clinic attendees. See Sexually transmitted disease clinic P attendees Papanicolaou test, for trichomoniasis, 694 R Parran Award Lecture, 477, 478 Race/ethnicity. See also African Americans Partner ag chlamydia and gonorrhea in incarcerated women and, 64 in discordant adolescent sex partnerships, 234 concordance between sexual behavior and sexual identity and, 110 STD prevalence in adolescent girls and, 211, 214 (editorial), 234 emergency-department screening in inner city vs. urban sites and, 143 Partner notification STD prevalence among urban day laborers and, 661 barriers to, 90 (editorial) Reactor grids, in syphilis surveillance, 650 for chlamydial infection, genotyping and, 205 Rectal gonorrhea, risk factors for, HIV status and, 813 for HIV and syphilis, effects of on sexual behaviors and relationship Reporting, of male-to-male sexual activity, 526 (letter) stability, 75, 83 Risk behaviors/factors. See also Condom use; Sexual behavior; Substance low coverage for gonorrhea, chlamydial infection, and HIV infection in, use/abuse 490 Patient-delivered therapy, for chlamydial infection, 509 of adjudicated African American adolescents, 634 in cross-border sexual networks, in Hong Kong, 827 Patient education, for HPV infection, 193 discordant sexual partners and, 234 Patient-performed sample collection, for cervicovaginal specimens, 107 306, 769, 880 early-onset douching and, 689 effects of partner notification on, 75, 83 Pelvic inflammatory disease emotional experience of intercourse as, 348 average lifetime cost of, 369 of females in New Independent States of Soviet Union, 680 clinical diagnostic codes for CDC case definition of, predictive value of, heterogeneity of, treatment planning and, 388 866 for HIV infection Penicillin. See also Antibiotics in Brazil, 166 N. gonorrhoeae resistance to changing attitudes toward, 764 in Canada, 896 impact of HAART on, 399, 562, 764 in Cuba, 10, 443 in Madagascar, 262 in India, 523 in Malawi, 183, 185 (letters) in Indonesia, 25, 178 in rural areas, 134 in Spain, 395 in HSV-2 infection, in females, 405 Perianal nodular herpes simplex virus infection, in AIDS, 157 of males with/without regular doctors, 512 Perianal warts, imiquimod 5% cream for, 124 of men who have sex with men, at sex resorts, 909 Peru in pregnant African American teens, 57, 211, 214 (editorial) cost-effectiveness of syndromic management in pharmacies in, stability of, in birth cohort, 818 STD prevention in, for sex workers, 273 in Thailand, 320 Pharmacies, syndromic management in Risk spaces, core group concept and, 825 (editorial) in Peru, 379 Rothenberg, Richard, Thomas Parran Award recipient, 477 in South Africa, 609 Russia Phthirus pubis, epidemiology of, 292 sexual habits and HPV infection in females in, 680 Polymerase chain reaction assay sex workers in for HPV, sampling methods for, 246 injection drug use by, 46 (editorial) microwell-plate—based, for Mycoplasma genitalium, 756 social organization of, 39 Pregnancy in African American teens, older partners and STD prevalence among, S 211, 214 (editorial) Sample collection, cervicovaginal, patient-performed, 107, 306, 769, 880 bacterial vaginosis in Sauna, male-only, gonorrhea and chlamydia screening in, 886 management of, 645 Screening Vol. 30¢No. 12 INDEX OF SUBJECTS for chlamydia enumeration of, in Madagascar, 664 in adolescents, 367 (letter) injection drug use by, in Russia, 46 age range for, 120 male, drug injection and sexual mixing patterns of, 571 in asymptomatic men, ligase chain reaction with/without leukocyte male clients of, behavioral surveillance surveys of, in Hong Kong, 620 esterase test for. See Race/ethnicity participatory mapping for, in Madagascar, 664 in community based mobile clinic, 654, 659 (editorial) screening for gonorrhea and chlamydial infection in, in Indonesia, 671 at male-only saunas, 886 social organization of, in Moscow, 39 risk factor vs. clinically based, 901 sociodemographic dynamics and STDs in, at Mexican-Guatemalan bor- emergency-department, in inner city vs. urban sites, 143 der, 266 for gonorrhea STD prevalence in, in Indonesia, 671 in Indonesian sex workers, 671 STD prevention in, 273 at male-oniy saunas, 886 STD treatment algorithms for, in C6te d'Ivoire, 284 in pregnancy, 728 SIS model, for assessment of intervention scenarios, 388 for hepatitis C, in STD clinic attendees, 340 Smoking, HSV-2 infection and, 405 for Medicaid patients, 723 Soldiers mobile community-based, effectiveness of, 654, 659 (editorial) female, chlamydia prevalence in, 539, 545 (editorial) for Peruvian sex workers, 273 male, HIV-infected, human herpesvirus-8 in fection in, 713 Self-sampling, for cervicovaginal secretions, 107, 306, 769, 880 South Africa Sentinel site surveillance, for chlamydial infection, 20 HIV-1 transmission in, migration and, 149 Sex resorts, for gay men, risk behavior at, 909 syndromic management in, role of community pharmacists in, 609 Sex trade. See also Sex workers Soviet Union, New Independent States of, sexual habits and HPV infection participatory mapping of, in Madagascar, 664 in females in, 680 Sexual activity, male-to-male. See also Men who have sex with men Spain reporting of, 526 (letter) cervical HPV infection in, 788 Sexual behavior. See also Risk behaviors/factors NV. gonorrhoeae resistance to ciprofloxacin in, 395 concordance of with sexual identity, racial/ethnic variations in, 110 seroprevalence among STD clinic attendees in, 876 female adolescent, nonexclusivity in romantic relationships in, 752 urethritis in, etiologic and epidemiologic trends in, 280 of females in New Independent States of Soviet Union, 680 Spatial bridging, in importation of gonorrhea and chlamydia, 742, 750 of older women, 216 (editorial) stability of, in birth cohort, 818 Specimen collection Sexual concurrency, quantitative assessment of, 6 of cervicovaginal secretions Sexual debut, douching and, 689 method preferred by incarcerated women, 306 Sexually transmitted disease clinic attendees self-sampling methods for, 107, 306, 769, 880 female condoms use by, 91 urine, for chlamydial infection, in males, 345 hepatitis C screening in, 340 Spermicides, acceptability and product choice as indicators of use of, 556 hepatitis C seroprevalence and risk behaviors in, : Students. See Adolescents; College students HIV seroprevalence in, 876 Substance use/abuse. See also Risk behaviors/factors Internet use by, 33 by adjudicated African American adolescents, 634 pubic lice in, epidemiology of, 292 HIV prevalence and, in Brazil, 166 risk factors and immunity for hepatitis B in, 914 HIV risk and, changing perspectives on, 764 treatment of symptomatic STDs at, 512 human herpesvirus type 8 infection and, 199 with/without regular doctors, STD burden and risk in, 512 by male sex workers, drug injection and sexual mixing patterns of, 571 Sexually transmitted diseases. See also specific diseases by sex workers, in Russia, 46 (editorial) CDC treatment guidelines for, need for revision of, 528 (letter) Swabs in incarcerated women, epidemiologic study of, 531 (letter) dry, for HPV polymerase chain reaction assay, in males, 246 prevalence of self-collected, for cervicovaginal specimen collection, 107, 306, 769, in pregnant women, in Vanuatu, 362 880 among urban Latino day laborers, 661 Syndromic management prevention of of bacterial vaginosis, with/without HIV-1 coinfection, | Internet information sources for, 15 of male STDs, in China, 327 needs assessment for, in China, 600 role of community pharmacists in in sex workers, 273 in Peru, 379 state policy support for, 614 in South Africa, 609 risk factors for. See Risk behaviors/factors Syphilis screening for. See Screening antibiotic prophylaxis for, 844 syndromic treatment of, in China, 327 declining rates of, AIDS mortality as cause of, 419 transmission dynamics in (Thomas Parran Award Lecture), 478 incubating, azithromycin for, cost-effectiveness of, 502 transmission of, gap length and, 221 mass treatment of, 297 Sexual mixing, spatial bridging and, in importation of gonorrhea and outbreak of chlamydia, 742, 750 (editorial) among men who have sex with men, 872 Sexual networks, cross-border, in Hong Kong, 827 targeting sex partner meeting location for, 53: Sexual partnerships partner notification for, effects of on sexual behaviors and relationship discordant stability, 75, 83 of high-risk adolescents, 234 patient characteristics with male-to-male vs. heterosexual acquisition, in of pregnant African American teens, 211, 214 (editorial) Canada, 310 gap length between, STD transmission and, 221 prevalence of, in pregnant women, in Vauatu, 362 quantitative assessment of, 6 screening for. See also Screening targeting meeting places for, in response to syphilis outbreak, 533 in Medicaid patients, 723 Sex workers surveillance for, reactor grids in, 650 chlamydia prevalence in, in Mexico, 195 syndromic management of, in China, 327 drug-resistant N. gonorrhoeae in, in Indonesia, 178 Syphilis reactor grids, 700 934 INDEX OF SUBJECTS ee eee eT ee en = Urine testing Tanzania for chlamydial infection genital ulcer disease in, etiology and HIV coinfection in, 1i4 acceptability of to adolescents, 850 HSV-2 infection in in males, 345 prevalence of, 187, 588 for gonorrhea, acceptability of to adolescents, 850 risk factors for, 187 vs. self-collected vaginal swab Telephone hotline, in Italy, 707 female military recruits’ preference for, 769 Tetracycline, N. gonorrhoeae resistance to, 10 incarcerated women’s preference for, 306 in Canada, 896 n Cuba, 10, 443 Vv n India, 523 accination n Indonesia, 25, 178 for hepatitis n Spain, 395 hepatitis A/B vs. hepatitis B vaccine for, 859 Thailand, adolescent risk behaviors in, 320 for men who have sex with men, 411, 425, 449, 685 Third world countries. See Developing countries among STD clinic attendees, 914 Thomas Parran Award Lecture, 477, 478 for STDs, acceptability of among college students, 774 Topical microbicide, acceptability of to adolescent girls, 854 ‘aginal discharge Transmission dynamics (Thomas Parran Award Lecture), 478 rapid diagnostic kit for, in Gambia, 483 Treatment, syndromic. See Syndromic management syndromic management of, with/without HIV-1 coinfection, | Treatment adherence, HIV-transmission risk behaviors and, 399 aginal douching Treatment planning, mathematical tools for, 388 early-onset, health beliefs and high-risk behavior and, 689 Trichomoniasis HSV-2 infection and, 405 in HIV infection, associated factors in, 839 reasons for continuing or stopping, 71 Papanicolaou test for, 694 aginal flora prevalence of, in pregnant women, in Vauatu, 362 abnormal. See Bacterial vaginosis treatment of effect of single-use Lactobacillus crispatus capsules on, 568 for sex workers, in Céte d'Ivoire, 284 Vaginal swabs, self-collected, for cervicovaginal specimen collection, 107, in syndromic management of urethritis, in Malawi, 516 306, 769, 880 U Vaginitis, treatment algorithms for, for sex workers, in Céte d'Ivoire, 284 ‘aginosis. See Bacterial vaginosis Ulcers. See Genital ulcer disease ‘alacyclovir, for genital herpes, in suppressive vs. episodic therapy, pa- Uncircumcised males, HSV-2 infection in females and, 405 tients’ preference for, 226, 232 (editorial) Ureaplasma urealyticum urethritis, epidemiologic trends in, in Spain, 280 ‘anuatu, STD prevalence in pregnancy in, 362 Urethral discharge, syndromic management of, in China, 327 Urethritis Ww detection of HPV : DNA on external genitali-aagge el of males with, 629 Warts, anogenital gnoonnogcoocncoaclo.c See Gonorrhea/gonococcal infection 5% imiquimod cream for, 124 nongonococcal frequently asked questions about, 193 chronic, chlamydial hsp60 antibody in, 129 etiologic and epidemiologic trends in, in Spain, 280 i syndromic management of, trichomoniasis treatment in, in Malawi, 516 Young Investigator Award (ASTDA), 477

See more

The list of books you might like

Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.
DMCA & Copyright: Dear all, most of the website is community built, users are uploading hundred of books everyday, which makes really hard for us to identify copyrighted material, please contact us if you want any material removed.
Copyright @ PDFdrive.to, 2022 | We love our users